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ABSTRACT
In recent years new radiotherapy systems have emerged that are utilized for
small tumour treatments with improvements to enable improved dose coverage
of the target. The treatment is accurate but still would benefit from a real-time
treatment monitoring with high spatial and temporal resolution sampling for
regular quality assurance (QA). A monolithic silicon diode array, the Magic
Plate 512 (MP512) was developed as a potential candidate for such QA. The
detector was design for use as an in-phantom 2D dosimeter and 2D
transmission mode detector for real-time dose measurements.
The first part of this thesis evaluates the radiation response of the Magic Plate
and the impact of an air gap immediately above the MP512. This air gap is then
optimize for using the MP512 for small field dosimetry in both photon and
electron fields. The output factor (OF), percentage depth dose (PDD) and
enhanced dynamic wedge (EDW) beam profiles were measured as a part of
these studies. The optimized air gap is then taken into account in the later
chapters that focus on in-phantom dosimetry using the MP512. MP512
response reduces with increasing air gap above the detector. The OF measured
with MP512 with air gaps of 0.5 mm and 1.2 mm show a good agreement with
OF measured with the EBT3 film (within ±2%) and MOSkin for 6 MV and 10
MV, respectively. Similar results were observed for the PDD measurement.
The EDW dose profile matched well with the EBT3 for the air gap of 0.5 mm
within ±2% (1 standard deviation) for all wedge angles. The PDD measured by
electron beams demonstrated no significant effect of the air gap size above
MP512 for all energies.
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The second part of this thesis demonstrates the use of MP512T as a
transmission detector. The influence of operating the MP512T in transmission
mode (TM) on the surface dose of a phantom was evaluated as a function of
different field sizes and distances from the solid water phantom to transmission
detector (Dsd). For all Dsd and all field sizes, the MP512T led to the surface
dose increasing by between 5% and 25% when in the beam, depending on the
configuration. The transmission factor of the MP512T ranged from 1.020 to
0.9950 for all measured Dsd and field sizes.
The last part of this thesis showed the correlation of transmission mode
response (TM) and dose mode response (DM) of the Magic Plate512
(MP512T) for different detector to surface distances (Dsd) and treatment field
sizes. The measured correlation between TM and DM was then employed to
predict the dose at dmax for regular fields, and intensity modulated fields. The
calculated dose for regular fields of 1 x 1cm2 and 4 x 4cm2 fell in the range of
[-2.18% and +1.95%] compared to the measured dose. For the calculated IMRT
planar dose at dmax and gamma criteria of 3%/3mm and 2%/2mm pass rates of
98.14%/90.5% and 97.22%/93.8% were found when compared to the dose
predicted by the TPS for Dsd 4 and 24cm, respectively. Good agreement was
also observed for these gamma criteria when comparing TM measurements
taken at Dsd 4 and 24cm with EBT3 yielding pass rates of 96.89%/92% and
97.53%/93.8%, respectively.
The thesis therefore ultimately demonstrates that the dose in the phantom can
be calculated based on TM measurements and these data represent the first step
in the development of real-time high spatial resolution 3D dose reconstruction
technique based on TM measurements from the MP512.
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CHAPTER 1
INTRODUCTION
Any radiotherapy treatment aims to give a high radiation dose to the tumour but as low
as possible to the surrounding healthy tissue. This aims to provide the maximum chance
of curing or shrinking a cancer while minimizing the risk of side effects. Many studies
demonstrate that such a high dose improves the outcome of tumour control, and a
corresponding low dose reduces normal tissue toxicity [1]–[4]. Advanced radiation
treatment techniques such as IMRT, VMAT, and SRS/SBRT have been used for
delivering a high a conformal radiation dose to the cancer. These advanced radiotherapy
techniques use a computer-controlled linear accelerator and typically consist of many
intensity-modulated treatment fields which are incident from numerous different beam
directions. Due to its complexity, high precision radiotherapy planning checks before any
patient can start the treatment is required.
The use of real-time dosimetry verification for a complicated treatment plans is
recommended [5]. This verification aims to immediately detect errors that may occur
during treatment delivery. High spatial resolution, real-time dosimetry devices are
therefore needed due to the complex radiation fields that make up the treatment plan.
The Centre for Medical Radiation Physics (CMRP) at the University of Wollongong has
developed a two-dimensional monolithic silicon diode array called Magic Plate 512
(MP512) with high spatial resolution. The detector is designed for use in both in-phantom
dosimetry and transmission measurements. Both modes of operation of the MP512 will
be characterized and optimized as part of the work presented in this thesis.

Chapter 1: Introduction

1.1 Thesis outline
This thesis describes the use of the monolithic silicon diode array Magic Plate 512 for
dose mode measurement and transmission mode measurements. Chapter 2 discusses the
relevant literature related to the work presented in this thesis. Chapter 3 describes the
design and fabrication of these two systems. Chapter 4 evaluates the impact of an air gap
on the MP512 response and optimization of this gap for in-phantom dosimetry. The
device is then characterized for its performance in small and standard treatment radiation
fields. The optimized air gap size from this chapter is then used for in-phantom dose
measurements in chapter 6. Chapter 5 investigates the effect on surface dose, as a function
of different field sizes and distances from the solid water phantom to transmission
detector (Dsd), of using the monolithic silicon detector MP512T in transmission mode. In
addition, the transmission factor for the MP512T and the printed circuit board (PCB) were
also evaluated. Chapter 6 investigates the correlation of transmission mode response
(TM) and dose mode response (DM) of the MP512T for different detector to surface
distances (Dsd) and treatment field sizes. The measured correlation between TM and DM
was then employed to calculate the dose at dmax for regular fields. A clinical application
using intensity modulated radiation fields was used to evaluate this correlation. Chapter
7 presents the overall conclusions arising from the results and data found in studies
presented in this thesis. The advantages, limitations and the future work of this device are
also discussed.
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CHAPTER 2
LITERATURE REVIEW

This chapter aims to provide an introduction to some of the advanced radiation treatment
techniques, including IMRT, VMAT, SRS and SBRT. An extensive background on the
dosimeters for both pre-treatment verification, real-time treatment verification and small
field dosimetry is presented.

2.1 Radiation Therapy
According to a study released by the World Health Organization (WHO), cancer is the
leading cause of death worldwide with the incidence increasing at a rate of 2% each year
from 2012-2017 [6], [7]. The three most used methods for this lethal disease treatment,
include surgery, chemotherapy and radiotherapy. It is estimated that more than 50% of
cancer patients would benefit from radiotherapy at some stage of their treatment course
[8].
Radiotherapy uses a high energy of ionising radiation to treat tumours. Ionizing radiation
works by damaging the DNA of cancerous tissue leading to cellular death [9]. The beam
can be delivered with various type of ionising particles such as electrons, photons (X-ray)
,gamma (Gamma Knife) and protons [10]. Several methods are used to deliver radiation
to the patient. External beam radiation therapy (EBRT) or teletherapy is the most common
method of radiotherapy. EBRT uses a linear accelerator to generate high radiation dose
delivery to a target from outside the patient body [11]. Other methods are internal
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radiation therapy or brachytherapy where the radioactive source is introduced directly
into a tumour [12], but this method is outside the scope of this thesis.
EBRT aims to maximise the radiation dose to the cancer cells while sparing normal
healthy tissue surrounded [13]. Some modern radiation treatment techniques have been
developed to achieve the treatment goal, such as intensity modulated radiation therapy
(IMRT), volumetric modulated radiation therapy (VMAT), stereotactic radiosurgery
(SRS) and stereotactic body radiation therapy (SBRT).

2.1.1 Intensity Modulated Radiotherapy (IMRT)

IMRT delivers non-uniform radiation fluence to the target through various directions of
the treatment beams from several gantry angles [14], [15]. With multiple beams, high
doses can be delivered to the target volume, especially in the curvature shape and low
dose to the critical organs [16]. To modulate the intensity of radiation, the change in the
Multi-Leaf Collimator (MLC) position in the field is optimized by the inverse treatment
planning system (TPS) based on advanced computing calculation [17], [18]. Inverse TPS
for IMRT has been described in detail and can be found in the literature [19]–[22].
IMRT has two methods of treatment delivery including step and shoot technique and
sliding window technique. With the step and shoot technique, the beam is on when the
MLC are stable and allow multiple segments per field to be given. The beams stay still
when the MLCs are changed from one segment to another. The sliding window technique
keeps the beam on while the MLCs move through the irradiated field [23], [24].
2.1.2 Volumetric Modulated Arc Therapy (VMAT)

VMAT technique is developed from the IMRT technique. While IMRT delivers the
radiation with static gantry, in VMAT the gantry is rotated around the patient for one or
4
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more arcs continuously [25]. A number of parameters are varied during the treatment
such as MLC shaping, dose rate, gantry speed and MLC orientation [26]. VMAT, in
principle, is able to provide higher conformal dose compared to IMRT dose delivery
because this technique uses all angles that are available in the inverse TPS to optimise the
dose distribution [27]–[29]. The variation of gantry speed and dose rate enhances the
significant advantage of VMAT and provides the shortest treatment time [30]. This
reduces the effect of patient movement and intra-fraction motion in between radiation
delivery. However, the physical constraints of the linear accelerator should be considered,
such as maximum gantry speed, maximum leaf speed and the MLC orientation constraints
[31]. Additionally, the angular dependence of dosimeter can be present, which must be
corrected for verification technique [32]. Studies suggest the use of VMAT rather than
IMRT for the complex treatment areas such as the head and neck region, prostate region
and nasopharynges region [33]–[35].

2.1.3 Stereotactic radiosurgery (SRS) and stereotactic body radiation
therapy (SBRT)

SRS and SBRT have been used for more than ten years to eliminate benign and malignant
lesions. The SRS had been developed to treat small brain tumours as well as functional
abnormalities of the brain that could not be surgically removed [36]–[39]. These treatment
techniques were initially developed to treat a small tumour which is usually less than 4
cm [40]. SRS delivers in a single treatment of fraction but in SBRT the treatment dose
delivered in a few focused radiation treatments, typically one to five fractions. These
treatments lead to a shorter overall course of treatment time compared to other treatment
techniques resulting in a reduction in radiation-related biological effects [41].

5
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SRS and SBRT are complex due to the use of small field delivery techniques using IMRT
or VMAT for SBRT employing either high definition MLCs and/or small circular cones
in the case of SRS to fit a tumour [42]. This technique also optimises the gantry angle and
weights with multiple isocentre or dynamically shaping the field during gantry rotation
by mini or micro MLC [43], [44].
The challenge for SRS and SBRT is to deliver accurately and precisely, high radiation
dosage to a small area target and minimise the dose to normal tissue. Thus, a specialised
planning and treatment delivery technique is needed. The treatment planning verification
is required to ensure that the patient will receive accurate and precise radiation treatment
[45], [46].

2.2 Quality Assurance (QA) and current QA tools

2.2.1 Introduction

The complexity of IMRT, VMAT and SRS/SBRT requires the precision of radiation
delivery [47]. The treatment would not be effective if the tumour received a radiation
dose less of than the prescribed dose. Additionally, the patient would develop radiation
sickness if the normal healthy tissue and the vital organ received more than the radiation
dose [48]. To ensure that the calculated radiation dose from the TPS is matched well with
the dose delivered to the patient, the dose distribution needs to be accurately verified
before, during or in between treatment fraction delivery [49]. Thus the treatment
verification becomes an important part of radiotherapy to provide a safe radiation delivery
and consistency in patient outcomes [50].
The treatment plan can be verified by transferring the patient plan to a phantom, measured
using a dosimeter and compared with the calculated or predicted dose by the TPS at the
6
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same points [51], [52]. The verification that mostly operates a day before the first
treatment fraction in the absence of the patient is called pre-treatment verification. This
procedure can detect some errors such as incorrect positioning of the MLC leaves; an
incorrect plan exported from the TPS to the Linac; or any accidental changes occurring
in the plan [53]. Thus, those errors can be corrected before the implementation of the
clinical patient treatment plan.
Various type of detectors have been used for pre-treatment verification; for example, there
is point dose measurement systems such as ionisation chamber (IC), a semiconductor
detector and metal-oxide semiconductor field-effect transistor (MOSFET) [54]–[57].
However, in a complex dose distribution, such as that used in advanced treatment
technique, point dose measurements is unsuitable as it requires multiple measurement
points for a treatment plan verification. A two-dimensional (2D) dosimetry techniques
such as Film dosimetry, 2D array detectors have been produced for measuring energy
fluence or absorbed dose in two dimensions [58], [59]. Additionally, to detect and
measure the dose over the entire treatment volume, 3D detectors have been used to verify
higher dimensionality measurements.
Factors leading to errors which can occur during the whole treatment procedure in
radiotherapy include patient miss positioning and a change in the patient’s anatomy due
to weight loss or organ movement [60]. Additionally, the treatment parameters such as
Linac setting and beam modifiers can be changed in between the pre-treatment
verification, which has been reported by Huang et al. [61]. There is a considerable demand
for real-time dose verification which enables real-time detection of major errors and can
assess the dosimetric impact quantitatively during radiation delivery [62].
Real-time verification can be carried out by using the transmission-type detector
positioned in the photon beam between the Linac head and the patient or by means of
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electronic portal imaging device (EPID) during the treatment. The commercial
transmission detectors such as COMPASS system (IBA, Dosimetry), Dolphin system
(IBA, Dosimetry) and David system (PTW-Freiburg, Germany) have been introduced for
real-time dose verification.
As mentioned above, the complexity of advanced treatment techniques with the use of
small field dose delivery requires the careful selection of the suitable dose measurement.
The ideal detector for radiation dose measurement should have the following
characteristics:
i)

The detector should be tissue equivalent and not perturb the radiation beam.

ii)

The detector should have the small sensitive volume to avoid the volume
averaging effect.

iii)

The detector should have a high dynamic range to manage with a large dose
gradient that may be present per fraction of the treatment delivery.

iv)

The detector should have energy, dose rate, directional independence and dose
response linearity [63]–[66].

In this section, a brief introduction of both pre-treatment QA tools and real time treatment
verification tools is presented.
2.2.2 Pre-treatment verification QA tools
2.2.2.1 Point Dosimetry

i)

Ionisation chamber (IC)

The ionisation chamber is widely used as an absolute point dosimeter [67]–[69]. The
detector can have a wide range of physical shapes depending on the specific requirements,
such as parallel plate chamber, concentrate cylindrical or a wire within cylindrical,
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thimble chamber, condenser chamber, extrapolation chamber and waterproof chamber
[13].
The principle of this dosimeter is to measure an ion-pair generated by ionising radiation
passing through the sensitive volume (gas cavity) of the detector. The ion-pair attach to
either in the positive plate (anode) and a negative electrode (cathode) which connects to
the battery to collect the signals. The diagram of an ionisation detector is shown in Figure
2.1.

Figure 2.1. The diagram of the ionisation chamber [70].

There are various operating regions of ionisation chambers depending on the voltage
applied [71], [72]. For the normal ionisation region, the chamber operates when the
amount of voltage is appropriated to collect all the ions produced in the active volume
(100V-400V). However, it is insufficient to cause an increase in ion pairs due to gas
amplification as the voltage increases [72]. The current read by the electrometer is
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converted to the absorbed as the dose is proportional to the total ionising signal (charge)
measured.
A change in air density in the chamber may occur as a result of changes in temperature
and pressure and may affect the reading as it will increase as the temperature increases or
as the pressure increases [73]. Therefore, to convert the measured ionisation signal to the
absorbed dose, a correction for temperature and pressure is needed [73]. The standard
protocols such as TG-51 or TRS-398 outline the procedures that deal with this process
[74], [75].
The ionisation chamber provides accurate and precise measurements and is recommended
for beam calibration with essential corrections. More advantages of the ionisation
chamber are its long-term stability, relative ease of use and instant direct read out [76].
However, the ion chamber indicates some volume averaging due to the detectors finite
size of sensitive air volume [77], [78]. This effect limits the use of ion chambers where
high dose gradients exist such as in complex treatment plans in IMRT, VMAT and
SRS/SBRT. The chamber can overestimate the dose in certain circumstances due to its
large volume [79]. Moreover, the under-response of the detector is presented in small
fields due to the volume averaging and needs to be corrected [69].
ii)

Semiconductor detector

A silicon diode is the most common semiconductor detector and also sometimes referred
to as a solid-state ionisation chamber. It is widely used in radiation dosimetry for radiation
protection, radiation imaging and radiotherapy dosimetry [76], [80]. The detector is
produced by taking pure silicon and doping it with phosphorus to produce n-type or with
boron to produce p-type material [81]. The n-type material semiconductor has a
significant number of free electrons compared to intrinsic silicon. The n-type is
electrically neutral due to the free electron positive donor ions. The p-type semiconductor
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has a significant number of holes compared to intrinsic silicon. The p-type is electrically
neutral due to the holes negative acceptor ions [82].
Unlike the ionisation chamber, diodes can be operated without a bias applied [83]. A
diode with an impurity of the opposite type is implanted into the surface region to create
a p-n junction. The p-n junction alters the local electron and hole densities as well as
creates the electrostatic potentials (built-in potential) in a diode close to the junction called
the depletion region [84]. In this region, the free electrons will recombine with the hole,
leading to diffusion of surplus charge carriers to the other material until thermal
equilibrium is reached. At this point, the fermi level is equalised. The remaining ions
create a space charge and an electric field stops further diffusion.
When ionising radiation passes through the diode, electron hole-pairs will be produced.
The free electron on p-type and the hole on n-type will diffuse toward the p-n junction
[81]. By applying the external voltage (V), the charges produced in the diode are swept
or drift across the depletion region under the action of the electric field and can be read
by the electrometer [80]. The diagram of the p-n junction is shown in Figure 2.2.

Figure 2.2. The diagram of p-n junction [85].
11
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The silicon detector shows high sensitivity compared to the ion chamber with the same
active volume. This allows the diode to be designed with an extremely small sensitive
volume giving rise to high spatial resolution measurements being able to be made [86].
Therefore, diodes are well suited to measuring in a high dose gradient region such as
beam penumbra region. It also provides for excellent charge carrier collection because of
high mobility and a long mean free path of the majority and minority charge carriers [87].
However, on the negative side, the occasional recalibration for diodes is necessary as they
suffer radiation response degradation due to radiation damage. The sensitivity of the diode
decreases with accumulated dose with both p-type and n-type diodes [88]. The radiation
response of the diode is also dependent upon temperature which should be taken into
account. Grusel et al. found that the diode signal is increased by about 1-3% per 10 °C
change in temperature [89].
Moreover, diodes yield over response to low energy photons ranging from 10 keV to 200
keV due to the high atomic number (Z=14) of the silicon relative to tissue (water). This
leads to an increased photoelectric effect in this energy range compared to water where
the Z is about 7 [68], [80].
iii)

MOSFET Dosimeter

The principle of the radiation sensitivity of a Metal-Oxide-Semiconductor Field Effect
Transistor (MOSFET) is based on the creation of ‘electron-hole (e-h)’ pairs similar to the
semiconductor detector. However, the relevant e-h pairs, when a MOSFET is used as a
dosimeter, are generated in the gate oxide. MOSFETs were first utilised for radiation
dosimetry by Andrew Holmes Siedle et al. in 1978 [90], and they have been used in
radiotherapy for decades [90]–[92].
When ionizing radiation passes through the silicon oxide layer (SiO2), the positive
charges drift under the electric field (if applied) and accumulate via traps at the Si-SiO2
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interface. The accumulation of these charges influences the current flow between the
source and the drain of the MOSFET for a given applied bias [93]. In a constant sourcedrain current configuration the difference between the threshold voltage measured under
the constant current, before and after radiation exposure, is a function of the absorbed
dose in SiO2 [94].
The MOSFET is small, and the gate oxide is very thin, providing the possibility of the
shallow dose measurement. Many papers discuss the use of MOSFET for surface dose
measurement as an in-vivo radiation dosimeter [95]–[99]. The MOSFET is not dose-rate
independent but does offer real-time readout. As the radiation sensitive property of the
MOSFET is of an integrating nature, the detector total dose history can be stored [93].
Similar to other semiconductor detectors, the MOSFET has temperature dependence and
a limited lifespan that should be taking into account with regular recalibration necessary
[76], [96].

2.2.2.2 Two-Dimensional (2D) dosimetry
i)

Film dosimeters

The traditional radiographic film consists of a base of thin plastic with a radiation
sensitive emulsion, silver bromide (AgBr) crystal, coated on one or both sides of the film
[100]. The interaction of radiation to the AgBr forms the latent image in the film. When
the film is developed, the small grains of metallic silver is reduced making the film
opaque [101]. This opacity is defined in terms of the optical density (OD) which is a
function of radiation dose exposed to the film [102]. The radiographic film has an
excellent spatial resolution (<1mm) and can be cut into various shapes of the different
area [102]. The development of an extended dose range (EDR) film allows radiographic
film to be used over a wider dose range than traditional films [103]. However, the
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requirement of chemical processing to develop or fix the image and the requirement of
darkroom facilities is leading to the decreasing usage of the radiographic film [104],
[105].
The self-developed film has been introduced by David Lewis and is referred to as
radiochromic film [106]. Unlike radiographic film, radiochromic film is self-processing,
eliminating the wet chemical processing step [107]. This film consists of a single or
double layer of radiation-sensitive organic microcrystal monomers, on a thin polyester
base with a transparent coating. This radiation sensitive monomer is polymerised by a
topochemical (solid state) process to form the film opacity without any latent image [108].
The radiochromic film material is close to tissue equivalent when compared to
radiographic films, and it can be measured in various ranges of high radiation dose (1-10
Gy) [107]. Thus, radiochromic film has been shown to be used as a QA tools in clinical
dosimetry [109]–[112].
The film is a high spatial resolution, large sensitive area QA tool. It provides a 2D
intensity map from a single exposure which can be converted to the 2D dose mapping by
using the calibration curve [110]. However, the film dosimetry is not generally used for
real-time measurement because the film developing takes around 24-48 hours to stabilise
the film response [106]. Additionally, the film response depends on many factors
including; the film plane orientation, densitometer/digitiser artefacts, temperature,
humidity and storage conditions [106], [113]–[116].

ii)

2D Ionisation chamber array

The PTW 2D ARRAY developed by PTW-Freiburg Germany is an example of 2D
ionisation array. The ARRAYS are available in two versions that provide different
numbers and sizes of ionisation chambers. Version 1 consist of 256 ion chamber arranged
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in a 16 x 16 matrix while Version 2 consists of 729 ion chamber in a 27 x 27 cm2 matrix.
Both versions cover the area of 27 x 27 cm2. The basic characteristic were studied by
Poppe et al. The detector demonstrates both short-term and long-term reproducibility
within 0.2% and 1%, respectively [117]. Poppe et al. examined the use of PTW 2D
ARRAY for IMRT verification. The plan was verified by placing the detector
perpendicular to the Linac gantry which was set to a 0-degree delivery [117], [118].
Another example of 2D ionisation chamber array is MatriXX (IBA dosimetry,
Scanditronix Wellhofer GmbH, Germany). This detector consists of 1024 ion chamber in
an active area of 24 x 24 cm2. The detector diameter is 4.5 mm with 7.62 mm to each
adjacent detector distance. Each detector has a sensitive volume of 0.08 cc. Yan et al.
reported that the detector has good dose linearity and provides stable long-term
reproducibility with respect to low dose rate dependence [119]. Wolfsberger et al.
characterised the angular dependency of MatriXX and found the discrepancies in detector
response (up to 11%) as a function of gantry angle (Anterior-Posterior VS PosteriorAnterior fields). This effect is due to air-high-Z material interfaces [120]. Han et al.
examined this detector for IMRT QA and found that the detector was successfully used
for IMRT QA, but the issues of the detector volume averaging effect were reported [121].

iii)

2D silicon diode array

MapCHECK (Sun Nuclear, Melbourne, USA) consisted of 445 N-type silicon diodes and
covered the active area of 22 x 22 cm2. The active volume of the detector is 0.8 x 0.8 mm.
MapCHECK separates into two areas; the outer band array has 2.0 cm horizontal and
vertical spacing. The inner band array with the area of 10 x 10 cm2 has 1.0 cm horizontal
and vertical spacing [122]. The detector response presents excellent dose linearity.
However, the N-type diodes have a temperature coefficient of 0.54%/°C. Thus, the
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detector storage at or close to the treatment room temperature is recommended [59]. As
a silicon diode detector, MapCHECK degrades as they accumulate dose. So, it is
necessary to check and update the array calibration annually regularly or as needed [123].
Several studies examined MapCHECK for IMRT and VMAT pre-treatment verification
[33], [124]–[126]. Liu et al. found that the detector presented inconsistency with a gamma
comparison (3%/3mm) and that this deviation increased when the IMRT plan is more
complex [119]. This might be due to the few sampling points within the field, especially
for small fields and the detector resolution influenced by the non-uniform detector
distribution spacing of between 7 mm and 14 mm.

2.2.2.2 Three-Dimensional (3D) dosimetry

Advanced radiotherapy typically delivers a dynamic radiation beam with the dose rate,
MLC geometry, and gantry angle continuously varying. The 2D dosimeter mentioned
above is often used to validate a treatment in a single planar dose distribution. To provide
the information in full 3D dose distribution throughout the entire treatment volume, 3D
dosimetry is required.
i)

ArcCHECK

ArcCHECK (Sun Nuclear, Melbourne, USA) is an example of a 3D dosimeter. The
detector consists of 1386 N-type diodes in a cylindrical phantom. This system was
developed for the rotational therapy QA. The diode air embedded with 10 mm spacing in
a spiral pattern to increase the spatial sampling rate. The cylindrical phantom is 21 cm in
diameter and length. The active volume of the detector is 0.8 x 0.8 mm. The detector
spacing is 1cm x 1cm, and smaller when projected at the different source to surface
distance (SSD). The basic characteristics of ArcCHECK were studied by Li et al [127].
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The detector showed the good response for short-term and long-term reproducibility, dose
rate dependence, dose linearity, dose per pulse dependence. Nevertheless, ArcCHECK
presented directional dependence. At the gantry 105°, the directional dependence was
varied about 9.1%[127]. ArcCHECK has been reported to be used for IMRT and VMAT
QA [128], [129].
ii)

Gel dosimetry

Gel dosimetry was first introduced in 1950 by Stein et al [130]. At that time, they studied
the colour changes in the gel containing dyes produced by radiation in aqueous solution.
The chemical change related to the absorption of radiation dose.
More recently, the dosimeter polymer gel is made from various agents which are sensitive
to radiation such as gelatine, agarose, Sephadex and polyvinyl alcohol [131], [132]. Gels
are nearly tissue equivalent. Thus, no energy correction is required for both photon and
electron beams. It can be modelled to any desired shape and have high spatial resolution.
The dose distribution was recorded in three-dimensions and can be read out by several
methods such as magnetic resonance imaging (MRI), computed tomography (CT) or
ultrasound technique [133]–[135].
Gel dosimetry became one choice of radiation dosimetry. It was previously used for
IMRT, VMAT, SRS and SBRT dose measurement [136]–[138]. The disadvantage of gel
dosimetry is that it’s processing is complicated and expensive. Reproducing the gels with
similar radiation sensitivity is difficult. The use of this dosimetry for routine radiation
measurement is limited [139].
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2.2.3

Real-time treatment verification QA tools

2.2.3.1 Amorphous Silicon Electronic Portal Imaging Device (EPID)
The EPID system consists of a flat panel array mounted on a retractable arm opposite the
Linac beam. It was primarily designed for daily imaging to verify the geometric accuracy
of radiation filed on the patient [140].
The new generation of EPID system is the amorphous silicon-based system. The EPID
system has been extended for the purpose of dosimetric verification related to image
information. There are several ways to use EPID as a dosimetry QA tool. One method is
to use the device to verify the MLC position by capturing a series of snapshot images
during a dynamic MLC prescription. This method can be operated both online and offline [141], [142]. Another method is to reconstruct the radiation dose to the patient by
using the exit images acquired by the system during the treatment [143]. This method
requires some corrections from the scattering of the build-up material [144]. The recently
used method is to convert EPID image to an incident fluence distribution and use as the
input to compute the dose to the patient by the back projection method [145].
The characteristics of EPIDs have been reported and mention that the response of an EPID
is linear with integrated dose and not dependent on dose rate [146], [147]. It is non-tissue
equivalent material and over sensitive to low energy photon beam. Image contrast with
high photon energy (MV) is lower than with kV beam used in diagnostic radiography
[148]. Thus, for the purpose of patient setup, the patient image is performed with the kV
source incorporated with the Linac gantry, e.g. Varian OBI system [149].
EPID has been used for IMRT plan verification with advantages over the traditional use
of films such as ease of use, real-time imaging display and instant comparison with TPS
[150], [151]. However, the procedure to convert the image to the dose is complex and it
is still a challenge for VMAT verification because of the dose rate changes continuously
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[152]–[154]. This leads to a phase shift between MLC leaf openings and the portal arc
[155].

2.2.3.2 DAVID System
DAVID system (PTW-Freiburg, Germany) is a transmission-type detector which has
been developed for only a standard Siemens Linac (Siemens Healthcare Pty Ltd,
Germany). The detector consists of a flat, vented translucent multi-wire ionisation
chamber [156]. The number of IC is equal to the number of MLC leaf pair of the Linac
machine. The device can be placed at the wedges or block tray slot or can be permanently
installed at the Linac head, which is only used for IMRT. The distance from one detection
wire to the next one is 4.31 mm [156]. Each wire of DAVID system corresponds to the
MLC leaf-pair to verify the movement of the leaf during IMRT treatment. The measured
signal of all wire is a dose area product of the transmitted photon beam and the total
radiation dose to the patient [156]. The influence of the detector, when used in
transmission measurements, has been reported by Poppe et al [157]. They reported that
there is radiation absorption by the chamber due to the tray factor and there is surface
dose perturbation especially at small field sizes. Karagoz et al [158] investigated the
David system for IMRT QA. They found that the deviations in leaf position of static
IMRT plan were within 3% from the first week of treatment with a strong correlation with
EPID. The deviation of leaf position is dependent on the intensity level.

2.2.3.3 Delta4 AT Discover
Delta4 AT (Scandidos AB, Uppsala, Sweden) consists of 4,040 p-type diode detectors.
The detectors have an active area of 1 mm in diameter [159]. The active detector covers
an area of 25 x 20 cm2 when the beam is projected to a distance of 100 cm source to axis
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distance. The device has various detector spacing, depending on the axis direction, e.g.
along the MLC leaf in X direction the detector spacing is 1.6 mm apart while in Y
direction space is 3.2 mm intervals. The overall detector thickness is 4.0 cm when placed
at 63.6 cm source to device distance [160].
This device is an additional component to a Delta4 PT (Scandidos AB, Uppsala, Sweden)
[161] which provides the pre-treatment QA data. Both systems share software to be used
during patient treatment. The patient pre-treatment QA data is used to calculate the virtual
dose based on the Delta4 AT measured data by the QA software [160]. The interval time
for transferring the Delta4 AT measured data to the software is 25 ms. The beam
perturbation when the device was in the beam path was evaluated. The surface dose
increase varies from 1% - 9% depending on photon energy and radiation field size [160].
The largest change in the percentage depth dose (PDD) measurement was observed at a
depth of 10 cm with 0.5% decrease in dose [160].

2.2.3.4 COMPASS
COMPASS (IBA Dosimetry, Germany) is a pixel segment 2D ionisation chamber array.
The array consists of 1600 air vented plane-parallel ion chambers. The detector’s active
volume is 0.02 cm3 in the active area of 40 x 40 cm2.The detector spacing is 6.5 mm
COMPASS can be attached to the Linac head (Varian Linac 2100iX). The source to
detector distance is 65 cm. Sankar et al. studied the influence of the COMPASS system
when used in the transmission mode for 6 MV photon beams. They found an increase in
the surface dose for shorter SSD and the large irradiated field. Beyond the depth of
maximum dose, the perturbation properties were in good agreement with the open field
[162].
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2.2.3.5 Dolphin dosimetry system
Dolphin dosimetry system (IBA Dosimetry, Germany) consists of 1513 air-vented planeparallel ionisation chambers. The active area is 24 x 24 cm2. Each chamber has a diameter
of 3.2 mm and 2 mm height. The pixel pitch is 5 mm in the inner detector area and
approximately 8 mm in the outer area with the active volume of 0.016 cm3 [163]. The
device corresponds to the COMPASS dosimetry software (IBA Dosimetry, Germany)
[163]. The surface dose increasing when the Dolphin detector was in the beam was found
the maximum about 11% at the SSD of 80 cm [164]. The influence on PDD measured by
dolphin detector was 1% beyond the depth of maximum [164]. Thoelking et al. evaluated
the clinical performance of this system and found that a good agreement for dose
reconstruction based on dolphin detector read-out compared to TPS was observed for
IMRT plans with a 3% error of MLC position [165].

2.2.3.6 The Integral Quality Monitoring system (IQM)
IQM system consists of an area integrating energy fluence monitoring sensor (AIMS) and
a calculation module (IQM_CALC). This detector is designed to be mounted with the
final beam shaping device, the MLC and the patient. The detector is made from
Aluminum and has a physical size of 22 x 22 cm2. The detector sensitive volume is
530 cm3 and can monitor the maximum radiation field size of 34 x 34 cm2 at the isocentre.
The principle of this system is that the dose measured by AIMS will be compared with
the predicted dose calculated by IQM_CALC. The signal from the ion chamber (AIMS)
provides spatially dependent dose-area-product for each beam segment. The calculation
dose (from IQM_CALC) is based on the integration method associated with the
information from the TPS. The signals from AIMS and IQM_CALC are compared in
real-time. Islan et al. studied the IQM system and found that the chamber attenuates the
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beam intensity by 7% and 5% for 6 and 18 MV beams, respectively, without changing
depth dose, surface dose and dose profile characteristic for field size 10 x 10cm 2 [166].
Although some transmission QA dosimetry devices are available, the spatial resolution
and beam perturbation for some of them make their use in clinical practice for the
advanced treatment technique such as SRS and SBRT for real time treatment verification,
questionable.

2.3 Center for Medical Radiation Physics (CMRP) semiconductor
dosimetry
Many devices have been developed for the purpose of advanced treatment technique QA
such as SRS and SBRT as mentioned previously. Due to the complexity of the SRS and
SBRT delivery with a very small field, there is a considerable demand for real-time dose
delivery verification with high-resolution detectors during patient treatment.
Center for Medical Radiation Physics (CMRP), University of Wollongong developed the
2D diode array Magic Plate 121 (MP121) as an online radiation detector. The detector is
based on small single epi-diodes embedded in a KAPTON carrier with pitch 1 cm and
overall thickness of 0.45 mm only. MP121 has been used as a transmission detector for
real-time dose monitoring in which the detector was mounted on the Linac head. The
detector presented minimal beam perturbation leading to an increase in the surface dose
of less than 0.5% [167]. However, the spatial resolution of the MP121 detector is
precluding its effectiveness for small field real-time QA.
A new detector, the Magic Plate 512 (MP512), has been developed with a better spatial
resolution. MP512 is a silicon monolithic with a low resistivity p-type substrate. The
detector consists of 512 pixels with a 2 mm detector pitch. The silicon detector arrays
with thickness 0.45 mm are wire bonded to a thin 0.5 mm tissue equivalent printed circuit
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board (PCB) and covered with a layer of resin to protect it from any accidental damage.
The use of MP512 in in-phantom dosimetry has been previously studied [168], [169].
Additional studies for in-phantom dosimetry of MP512 will be presented in Chapter 4.
The dose mode measurements such as output factor, percentage depth dose and beam
profile with different air gap size above the detector will be evaluated with various field
sizes (include small field size) for both photon beams and electron beams. The following
chapters (chapter 5, chapter 6 and chapter 7) present the use of a thin transmission
monolithic MP512 detector as a transmission QA tool.

2.4 Small field dosimetry
Advanced radiation treatment techniques such as SRS and SBRT traditionally use small
radiation fields in sub centimetre range to treat tumours and spare normal tissue.
IAEA/AAPM define a small field as a field where the dimension is smaller than the lateral
range of the charged particles. Generally, the small field is defined as a filed size of less
than 4 x 4 cm2 [170]. There are three existence conditions represented in small filed
dosimetry and are discussed below.
2.4.1 A loss of lateral charge particle equilibrium (LCPE).

LCPE is a part of charge particle equilibrium (CPE) associated with a range of secondary
electrons [171]. CPE effect can be explained by the Bragg Gray cavity theory. In this
theory ionisation chamber (IC) is used as a reference detector and assumes that it does
not disturb the particle fluence when inserted into a medium [172]. The CPE exists for
volume v when the energy absorbed per unit mass equals the energy imparted per unit
mass [171]. This means the ionisation produced within the gas-filled cavity inside the

23

Chapter 2: Literature Review

medium is proportional to the energy absorbed. Therefore, absorbed dose (D) equals total
kerma of primary radiation photon (ratio =1).

𝐷
=1
𝐾𝑐𝑜𝑙𝑙
In a photon beam the kerma is defined as the initial kinetic energy of all charged particles,
mainly electrons and positrons, liberated by photon interactions per unit mass in a
medium. Since part of this kinetic energy may be converted back to energetic photons
mainly through bremsstrahlung and annihilation in flight processes it is useful to analyses
that part to the kerma which remains as kinetic energy of charged particles, namely the
collision kerma, kcol [173], [174].
When the field size decreases, the variation of electron fluence depends on the radiation
field size [175]. The maximum of secondary electrons range is larger than the closest filed
edge. This causes an uncertainty of the dose in the small field compared to the calibration
filed where Bragg Gray cavity is broken down, and lateral charge particle disequilibrium
occurs [176].
Another concept of CPE was explained by Das et at. They stated that the beam is broad
and parallel. Thus, there exists an artificial source everywhere to compensate for any
photon loss during interaction [177]. LCPE is used for nonstandard beam and is used for
an infinite flat, broad beam and homogeneous phantom where the photon fluence is
laterally uniform at all depths and in all directions for all energies [178]. The loss of
scattered photons for each primary photon is replaced by scattered photons which is
generated by other primary photons in the beam direction. If the medium is changed, the
number of photons and scattered photons generated laterally depend on the properties of
the medium such as medium density. So LCPE can no longer be existed [179]. In a small
field, a lack of LCPE is considered when radiation direction passes through an
24
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inhomogeneous medium including the detector. Hence the correction for beam
perturbation in an inhomogeneous medium is needed for the detector [177], [179].

2.4.2 Partial source occlusion

The photon fluence from the Linac machine consists of primary photons and secondary
photons. The former generates directly from the target focal spot while the latter is
produced from the structure of Linac head as the scattered photons [180]. Generally, the
target is spread over the area, and the source profile size is determined by full width at
half maximum (FWHM) [13]. The beam size is collimated by the collimators. By
decreasing the collimator setting, the field size decreases. The primary photon and
scattering photon is blocked by the collimator leading to a reduction in the absorbed dose.
Moreover, the FWHM of the source profile is reduced when decreasing the collimator
setting [181]. Thus, the small field size output is lower than the field size at which the
whole source can be seen from the detector point of view as shown in Figure 2.3.
[177], [178], [182].
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(a)

(b)

Figure 2.3. (a) Broad beam and (b) small beam from the detector point of view.

2.4.3 The detector volume averaging effect

The radiation dose measured by a dosimeter is associated with the averaging charge over
the entire sensitive volume of the detector, where the dose is proportional to a number of
charged particles [183]. To measure the accurate dose, the detector should be irradiated
uniformly. In a small field, a steep dose gradient can be affected by the dosimeter which
has a large sensitive volume compared to the radiation field size. A flat field profile
includes a portion of penumbra might be measured over the sensitive volume [178]. The
measured dose would not be accurate and may result in reduced signal [78].
The dose calculation for treatment planning requires beam data to drive the calculation
model such as output factors [184]. When measuring the output factor for SRS/SBRT
field (small field) with a large dosimeter, an underestimation of the output factor will be
present in the measurement. The incorrect beam parameter for dose calculation would
cause the miscalculation which significantly affects the treatment [185], [186]. So the
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high spatial resolution dosimeter with a small active volume and good reliability which
minimise the volume averaging effect is important for small field dosimetry [178].

2.5 Skin and surface dose
The International Commission on Radiation Units and Measurements (ICRU) and the
International Commission on Radiological Protection (ICRP) recommend the skin depth
for practical dose assessment should be at a depth of 0.07 mm below the surface. This
depth is the deepest layer of the epidermis and lies above the basement of the membrane
and is also known as the basal layer [187]–[191].
Many studies have shown that in radiotherapy, the skin dose is affected by changing in
parameters such as patient geometry, beam energy, SSD, field size, the use of wedges,
blocks, block trays, thermoplastic mask and bolus [192], [193].
Yadav et al., estimated the skin dose for various beam modifiers and SSD for 6 MV
photon beams. They found that skin doses were increased as the SSD decreased and were
dominant for larger field sizes. The measured skin dose due to a motorised 60° wedge for
the 10 x 10 cm2 field was 9.9%, 9.5%, and 9.5% at 80 cm, 100 cm and 120 cm SSDs. The
measured skin dose due to acrylic block tray, of thickness 1.0 cm for a 10 × 10 cm2 field
was 27.0%, 17.2% and 16.1% at 80, 100 and 120 cm SSD, respectively [194].
Doracy et al. have measured 79% of the maximum dose when treating through the
material versus 22% of the maximum dose when no beam modifier or immobilisation
devices are used [193].
Kim et al. confirmed that the skin dose increased as the field size increased. They showed
that for all field sizes the skin dose increased with the use of block tray; 7% to 59% for 8
MV and 5% to 62% for 18 MV beam [195].
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Several radiation detectors have been used to investigate the surface dose and build up
regions such as a parallel-plate ion chamber, TLD, film and MOSFET. Each detector has
its own advantages and disadvantages that may make it more favourable than the others
in the various applications.
TLD can be used for in vivo dosimetry because of its low cost and tissue equivalent. The
extrapolation method is used for TLD skin dose measurement. However, it cannot read
in real-time due to the complexities of TLD processing [196]. Film dosimetry has been
used for surface dose measurement due to the effective film depth being near the basal
layer and its high spatial resolution. So it is not necessary for any correction unlike the
dose measured by the ion chamber [197]. However, film dosimetry is time-consuming
and the signal can be affected by many parameters which have been discussed previously
in 2.2.2.2 [198]. Rosenfeld et al. promoted MOSFET for surface dose measurement. The
MOSFET data showed excellent agreement with the reference chamber (Attix ion
chamber) in the build-up region. It is small in size and has a simple reading circuit which
can be read out online [92], [93].

2.6 Gamma evaluation
The gamma evaluation method as presented by Low et al. [51] is designed to compare the
measured dose distribution and the calculated dose distribution. Figure 2.4 shows a
diagram of the gamma evaluation method. This figure is presented for a single
measurement point. Generally, all measurement points are repeated for the comparison in
the clinical practice. The measured dose (rm) is used as reference information, and the
calculated dose (rc) is queried for comparison. X and Y axes are the spatial locations of rc
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and the Γ axis represents the difference between the measured dose [Dm (rm)] and
calculated dose [Dc (rc)].

Figure 2.4. A diagram of the gamma evaluation method [51].
The acceptance criteria are defined by ∆DM for the dose difference and ∆dM for the
distance to agreement. The acceptance criteria is an ellipsoid defined by

∆𝑟 2 ∆𝐷 2
1= √ 2 +
2
∆𝑑𝑀 ∆𝐷𝑀

where ∆r is the distance between the reference and compared point

∆r = │rm - rc│

and ∆D is the dose difference between dose distribution at rm (Dm) and rc (Dc), Thus

∆D = Dc(rc)-Dm(rm)
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A quantitative measure of the accuracy of the correspondence is determined by the point
with the smallest deviation from the reference point lying within the ellipsoid of
acceptance, i.e. one point for which:

𝛤𝑚 (𝑟𝑐 , 𝐷𝑐 ) = √

∆𝑟 2
2
∆𝑑𝑀

+

∆𝐷2
2
∆𝐷𝑀

≤1

The pass and fail criterion therefore become
Γ(rm) ≤ 1, correspondence is within the specified acceptance criteria.
Γ(rm) > 1, correspondence is not within specified acceptance criteria.
An implicit assumption is made that once the passing criteria are selected, the dose
difference and DTA analyses have equivalent significance when determining calculation
quality.
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CHAPTER 3
METHODOLOGY
In the previous chapter, the QA tools for advanced treatment techniques for both pretreatment and real-time treatment were reviewed. The development of a new silicon diode
detector array ‘MP512’ was introduced as a QA system. This chapter describes the Magic
Plate 512 detector system that was used in this thesis for in-phantom dosimetry and
transmission dosimetry. The electronic readout system will be described as well as other
detectors that have often been used to compare with the MP512 dose response.

3.1 Linear accelerator and field arrangement
For the work described in this thesis, the photon beams and electron beams were
generated by a linear accelerator Varian model 2100IX (Varian Medical Systems, Palo
Alto, CA). All experiments were performed at the Illawarra Cancer Care Centre,
Wollongong Hospital, Wollongong.
The Linac provides dose rates of between 100 MU/min and 600 MU/min with 100
MU/min increments. The maximum MU that can be delivered is 9999 MU for any one
treatment. The field size in this study is defined at the 100 cm SSD. The field sizes are
collimated by the Linac jaw and MLCs and varied from 1 x 1 cm2 to 20 x 20 cm2.
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3.2 Magic Plate 512
The Magic Plate 512 (MP512) was designed and developed at the CMRP. It is a 2D array
of isolated p-i-n silicon diodes embedded together in an ion-implanted silicon monolithic
diode detector, manufactured on a bulk p-type substrate. The silicon substrate is 0.45 mm
thick. The MP512 array consists of 512 pixels with a detector array-element size of 0.5 x
0.5 mm2 and pitch 2 mm with an overall dimension of 52 x 52 mm2 as shown in Figure
3.1. The MP512 monolithic detector is mounted and wire bonded to a printed circuit board
(PCB) 0.5 cm thick and covered by a thin layer of resin to preserve the silicon detector
from moisture and chemical contamination and to protect the wire bonds [168].

Figure 3.1. Magic Plate 512 bounded with the PCB

The PCB provides the fan-out for connecting the sensor to the readout electronic system.
The MP512 detectors operate in passive mode and have no bias voltage applied to the
diodes. In this thesis, a thin monolithic silicon detector MP512 was designed to operate
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in both dose mode measurement (in-phantom) and transmission mode measurement
arrangements.
3.2.1 Magic Plate 512 for in-phantom measurement

To use the detector for in-phantom dosimetry, the MP512 was placed between two
polymethyl methacrylate (PMMA) slabs to protect the detector from mechanical damage
and shielding the sensor from ambient light [199]. Figure 3.2 presents the MP512 and the
schematic diagram of MP512 embedded for in-phantom measurement. Some
characterisation of MP512 and the use of detector as an in-phantom QA tool has been
previously reported [168]. In this thesis work, the characterisation is extended
significantly as it focused on operating the device in transmission mode. In chapter 4,
more details of the detector characteristics will be studied such as the effect of the air gap
on detector response and the optimisation of the suitable air gap size upstream of the
silicon detector.

(a)
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(b)

(c)

Figure 3.2. (a) MP512 detector wire bonded to the PCB sandwiched with the two
PMMA slabs, (b) MP512 when used in dose mode in phantom dosimetry and (c) a
schematic diagram of the MP512 packaged between two PMMA slabs.

34

Chapter 3: Methodology

3.2.2 Magic Plate 512 for transmission mode measurement

To use MP512 as a transmission detector, the detector is embedded with different
packaging. The detector is sandwiched between 3 mm thick PMMA sheets with an
opening area of 9.5 x 9.5 cm2 at the centre of the board in both front and back of the
detector to generate a 0.45 mm thick transmission detector.
When operating the MP512T in transmission measurement mode, the detector is covered
with a black plastic sheet (80 µm), to reduce light leakage to the detector. The MP512T
is placed on a movable stand holder which has the capability of moving in a vertical
direction. Moving the detector along the beam axis between the patient surface and the
Linac head enables the detector to change the effective spatial resolution that the radiation
field is sampled. The concept of a movable transmission high-resolution detector and
more details will be explained in chapter 5. Figure 3.3 shows the MP512T when used in
transmission dosimetry and the detector packaging schematic.

(a)
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(b)

(c)
Figure 3.3. (a) MP512T detector wire bonded to the PCB and sandwiched with the two
PMMA slabs with the opening in place of the detector, (b) MP512T placed on the
movable stand holder when used in transmission mode measurement (c) A simplified
schematic of MP512T packaging
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3.3 The data acquisition system (DAQ)
The MP512 data acquisition system was custom designed at the CMRP. The system is
based on a multichannel electrometer chip named AFE0064 from Texas Instruments. The
AFE0064 chip is a current integrator which consists of 64-channels. For each channel,
the analogue differential output which is proportional to the charge accumulated in a
capacitor during a particular configuration is provided. The chip is set electronically
through a serial protocol interface on the lowest gain available to span the full scale up to
9.6 pC, with a resolution of 16 bit and a non-linearity of less than 0.1% [200].
The DAQ system uses eight AFE chips to readout all the 512 channels, and the MP512
signal is synchronized with the Linac pulse. It is read out by four analogue-to-digital
(ADC) converters. When the beam is on, all acquisitions were synchronised to the Linac
trigger signal by a field programmable gate array (FPGA). The FPGA DAQ and the Linac
machine is connected to each other by means of a coaxial cable. The FPGA itself connects
via a USB 2.0 link to the host computer. The signal from each pixel is acquired in
synchronisation with each Linac pulse (pulse-by-pulse) or by using an internal trigger at
a frequency of up to 5 MHz. More details about DAQ system can be found elsewhere
[201].
The CMRP furthermore designed the graphical user software for external beam
radiotherapy which provides real-time visualisation and flat field correction, however not
part of this thesis work. While the beam is on, the interface is able to present in both
instantaneous detector response and integral detector response Figure 3.4 shows the
software interface for reference and all the commands for the device controller.
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Figure 3.4: The AFE-MP512 software interface version 1.37.

Due to the different in operational characteristics of photon beam and electron beam
production, the relevant parameters used in the software interface setting was set as shown
in Table 3.1.

Table 3.1. Relevant parameters for controlling the AFE-MP512 software interface for
photon beams and electron beams.
Parameter

Photon
7
4096
15
78
0.36
65

Range
Buffer size (kB)
Acquisition Length (s)
Integration time (µs)
Frequency (kHz)
Integration time of offset (µs)
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Electron
7
4096
20
20
0.18
65
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3.4 Ionisation chamber
In the thesis work described here, two types of ion chambers were used including the
Farmer IC and Markus IC and both are often used as a comparative dosimetry in clinical
settings. The following details are briefly discussed regarding these two detectors.
3.4.1 Farmer ionisation chamber

A Farmer chamber (Model 2517A) was used in this thesis for transmission factor (TF)
measurements. A Farmer ionisation chamber is a thimble-type (or cylindrical) chamber
which is a fundamental tool for medical dosimetry. The chamber has a cylindrical cavity
in which an electric field is applied between a conductor coated on the inner surface wall
and collector electrode that lies along the centre of the cavity. The leakage current from
the high voltage electrode is prevented by the guard electrode of the thimble chamber.
The ion-collecting volume is also defined by this guard [202]. Figure 3.5 schematically
presents the thimble ionisation chamber. The thimble wall is often made of pure graphite
and the central electrode of pure aluminium with the typical air volume between 0.051.00 cm3. The wall material is designed to be thick enough to establish CPE or TCPE or
thin enough not to perturb the fluence of charged particles. The wall thickness is about
0.1 g/cm2. The chamber is at the ground and the guard is kept at the same potential as the
collector. The chamber radius is typically 2-7 mm and length 4-25 mm [203].
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Figure 3.5. The schematic representation of thimble ionisation chamber [204]

3.4.2 Markus ionisation chamber

Markus ionisation chamber (Model N23343) was used in this thesis for surface dose
measurements and percentage depth dose measurements. The Markus is a plane parallel
ionisation chamber. It has been recommended for the surface dose measurement for
photon beams and electron beam [173], [205]. This chamber has a flat cavity which can
minimise in-scattering perturbation effect. The detector consists of a guard ring
surrounded by the collecting electrode. The purpose of guard ring is to prevent undue
curvature of the electric field over the collector [173]. An electrode spacing of the detector
is about 1-2 mm, and the sensitive volume is 0.35 cm3. The collecting surface on an
insulator is coated with graphite. Figure 3.6 shows a schematic of a parallel plate
ionisation chamber.
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Figure 3.6 Schematic drawing of a parallel plate ionisation chamber

Markus ionisation chamber is a good alternative as the extrapolation chambers. However,
this chamber is known for their over-response due to the secondary electron generated
from their small guard ring and their internal dimensions [206]. Generally, this effect
occurs only at build-up region [207].
All data measured by Markus IC in this thesis is corrected for detector over-response by
using Velkley correction as modified by Rawlinson [208], [209]. The chamber dimension
used for correction calculation was obtained from Chen et al. as shown in the equation
(3.1), (3.2) and (3.3) [210].

𝑃(𝑑, 𝐸) = 𝑃′ (𝑑, 𝐸, 𝐺) − 𝜉 (𝑑, 𝐸, 𝐺)

(3.1)

𝜉 (𝑑, 𝐸, 𝐺) = 𝜉 (0, 𝐸, 𝐺) 𝑥 𝑒 −4.0𝑑/𝑑𝑚𝑎𝑥

(3.2)

𝑠

𝜉 (0, 𝐸, 𝐺) = 𝑐(𝐸) 𝑥 (𝑤) 𝑥 𝜌0.8
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Where P is the true PDD and P′ is the measured PDD. The ξ is an over response correction
factor, E is the photon energy, d is the depth in the phantom, 𝜌 is mass density of the
chamber wall. The s/w is the ratio of electrode separation to the diameter of wall. For 6
MV and 10 MV photon beam dmax = 1.5 cm and 2.1 cm, respectively. As mentioned in
Rawlinson study, the c(E) for 6 MV is 27% and for 10 MV is 18.41%. All parameters for
the original Markus IC is shown in Table 3.2.

Table 3.2. The original Markus Ionisation chamber specification [211].
Wall (w)
Material

Collecting electrode

Polymethylmethacrylate

Density (g/cm3)
Diameter (mm)
Separation (mm)
Thickness(mg/cm2)

1.189
6
˗
˗

Graphited PMMA
1.189
5.3
2
˗

Window
Polyethylene
(CH2)
0.93
˗
˗
2.5

3.5 Radiochromic Film dosimetry
Gafchromic EBT3 film (ASHLAND, Wayne, NJ) was often used for comparison with
the dose measured by MP512 such as output factor, wedge beam profile, PDD and IMRT
plan dose measurement. The characteristic and the usefulness of the EBT3 was briefly
described in Chapter 2. This section will explain the film workflow that performed in this
thesis.
3.5.1 Calibration phase

To characterise the radiation dose sensitivity curve of a batch of EBTS film, dose
calibration measurements were performed.
The film sheet was cut into multiple pieces with the size of 3 x 3 cm2. In this thesis, 12
pieces were used for clinical practice. Each film was Pre-scanned before exposure by a
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Microtex ScanMaker i800 scanner. In order to warm up the scanner for better film
analysis consistency, each film was scanned six times, and the last three scan were kept
for analysis [113]. The film was positioned at the centre of the scanner and was scanned
in 48-bit RGB colour mode with 70 dpi scanning resolution. All films were placed in the
same orientation to minimise any uncertainties [113].
For film dose calibration measurement, the film was positioned at dmax (1.5 cm for 6MV)
in a solid water phantom and aligned at the beam centre. The full backscatter condition
was set with 10 cm thick of solid water. A known dose ranging from 0 – 40 Gy was
delivered to each film. All calibration setup was repeated for 10 MV photon beams.
All films were kept for at least 48 hrs for full development at the unexposed UV area to
avoid any possible darkening of the film [212]. The post-scanning were perform to
produce the image with the similar scanner setting as the pre-scan.
To obtain a calibration data from the scanned images, a set of multiple dose optical
densities (OD) was investigated by two software tools including; the Image J version
1.48v (National Institute of Health) and MATLAB (The Math Works Inc., Natick, MA).
The scanned image consists of 3 components; red, green and blue channels, only the red
channel is used for the dose conversion. Find the average intensity of the interested area
(at the centre of the film each film) and convert the intensity to the optical density (OD)
by equation (3.4) [109].

𝐼

𝑂𝐷 = log ( 𝐼0 )

(3.4)

Where I is the intensity (post-scanning value), and I0 is background intensity (prescanning value)
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Then plot the OD vs the known dose to generate the calibration curve [113], [213]. Devic
et al. and Battum et al. recommended to fit a non-linear calibration curve with a second
or higher order polynomial to generate the calibration equation[214], [215]. Figure 3.7
shows the example of the calibration curve used in this thesis.

600
y = 1256.5x2 + 908.98x - 4.1222
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0
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0.35
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Figure 3.7. The calibration curve for 6MV photon beam

3.5.2 Measurement phase

Similar to calibration phase, film sheets were cut into the desired size for clinical
measurement. For instance; the film was cut into a size of 7 x 7 cm2 for output factor
measurement and 10 x 10 cm2 for IMRT plan delivery. Pre-scanning was performed to
obtain a background intensity.
A blank EBT film was then irradiated to the radiation field of interest. A waiting time is
similar to the calibration phase, and then post-scan the film. The images were converted
into the dose distribution by converting OD value into the dose using the calibration

44

Chapter 3: Methodology

equation. The average uncertainty calculated across all measurements by film dosimetry
in this thesis is approximately 1.98%.

3.6 MOSkin dosimetry
MOSkin was often used as a comparison dosimeter in the part of surface dose
measurement. The MOSkin is a Metal-Oxide-semiconductor Field Effect Transistor
(MOSFET) designed and built at CMRP.
It was designed using a p-MOSFET sensor with a thick gate oxide and sealed within a
Kapton pigtail strip using drop-in technology [216]. A film layer protects the detector
from any moist and dust and build layer up providing a water equivalent depth of 0.07mm
[216]. More advantages of MOSkin are its small physical size and provide real-time
reading [217]. Figure 3.8 shows a MOSkin dosimetry system and its schematic.
The characteristic of MOSkin has been previously reported. It showed excellent
reproducibility and linearly for dose range of 50 cGy to 300 cGy. MOSkin presented
stability response to various factors such as SSDs, field sizes, surface, radiation incident
angles, and wedges [216]. It is found to be suitable for in vivo skin dosimetry in
radiotherapy [217]–[219].
Similar to MOSFET principle, the difference between two threshold voltage values, ∆Vth,
was calculated to find the measured absolute dose using the following equation (3.5). The
calibration factor was initially measured for 10 x 10 cm2 field at a depth of dmax. The time
gap between two signals was set at 30 seconds [220].

𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 (𝑐𝐺𝑦) =

∆𝑉𝑡ℎ (𝑚𝑉)
𝐶𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝐹𝑎𝑐𝑡𝑜𝑟 (𝑚𝑉/𝑐𝐺𝑦)

45

(3.5)

Chapter 3: Methodology

(a)

(b)
Figure 3.8. (a) A MOSkin dosimeter system and (b) MOSkin schematic.
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CHAPTER 4
OPTIMIZATING THE UPSTREAM AIR GAP
OF THE MAGIC PLATE 512 WHEN
OPERATING IN DOSE MODE
This chapter evaluates the impact of an air gap on the MP512 response when operating
in dose mode for both photon beams and electron beams, i.e. output factor, PDD and
beam profiles.

4.1 Introduction
Two-Dimensional (2D) silicon diode arrays implemented in radiation therapy quality
assurance (QA) applications have a lot of advantages such as real time operation, the
small size of the sensitive volume of a single diode and a large dynamic range. However,
currently most diode arrays have a detector pitch that is not suitable for routine use in
small treatment field applications [59], [122], [221], [222].
The CMRP introduced a monolithic high spatial resolution silicon detector called Magic
Plate (MP512). A silicon monolithic detector, the MP512 has a high spatial resolution,
yet a large, overall size and requires packaging that is associated with non-water
equivalent materials and air gaps that can affect small field dosimetry measurements.
The air gap has a significant impact on small field dosimetry since a loss in charge particle
equilibrium can occur depending on the size of the low density cavity [223], [224].
Several studies have shown that the reduction in dose is affected by increasing the air gap
size.
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Charles et al [225] reported the effect of very small air gaps, less than 1 mm, on small
field dosimetry used for stereotactic treatments. They simulated by Monte Carlo, the
response of an optically stimulated luminescent dosimeter (OSLD) in a 6 mm x 6 mm
6 MV photon field. A dose reduction of about 5% for an air gap of 0.5mm upstream of
OSLD relative to the simulation with no air gap was observed. A 0.2 mm air gap caused
a dose reduction of more than 2%. The authors also noted that the thin air gap can cause
a significant reduction in the measured dose.
In addition, the air gap can be useful for correcting the response of non-water equivalent
detectors in small field dosimetry [226]. Charles et al [226] demonstrated that silicon
diode overresponse relative to water in small fields can be neutralised by a small upstream
air gap which depends on the diode design and its packaging. That approach led to the
“air diode” concept for stereotactic dosimetry [227].
In this chapter, the effect of the upstream air gap on the response of MP512 is
investigated. The air gap size that changes the response of the MP512 to water in small
field dose measurements was optimized for both photon beams and electron beams. The
parameters tested were:
(a) Output factor (OF)
(b) Percentage Depth Dose (PDD)
(c) Wedge beam profile
The responses of all tests above with different sized air gaps upstream of the MP512
detector was measured in comparison with EBT3 film, the MOSkin, and an Ionisation
Chamber (IC).
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4.2 Materials and Methods
4.2.1 PMMA slabs for MP512 cover

The MP512 detector was placed between two polymethyl methacrylate (PMMA) slabs.
The purpose of the PMMA envelope is to protect the detector from mechanical damage
and to shield the sensor from ambient light [199]. Figure 4.1 shows the MP512 enveloped
with the PMMA slabs and an example of the PMMA slabs with an aperture at the centre
area. This aperture created an air gap between the detector itself and the PMMA slab as
presented in the schematic diagram shown in Figure 4.2.

(a)
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(b)
Figure 4.1. a) The MP512 enveloped with the PMMA slabs b) the PMMA slabs with
different air gap size

Figure 4.2. The simplified schematic of the MP512 packaging

By altering the size of this air gap it is possible to affect dosimetric measurements in
different radiation fields. To investigate the best air gap size for the MP512 detector, the
air gap thickness between the PMMA slab and the PCB used in this study was adjusted
between 0.5 mm, 1.0 mm, 1.2 mm, 2.0 mm and 2.6 mm from the PCB surface. Taking
into account the thickness of the silicon substrate is 0.45 mm, the actual air gap size above
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the MP512 for the studies described here are therefore 0.05 mm, 0.55 mm, 0.75 mm, 1.85
mm and 2.15 mm.
4.2.2 MP512 equalisation

Before performing and dosimetric measurements, equalization of the detector is required
because the MP512 consists of 512 silicon pixels and each pixel is connected to an
individual readout input of the multichannel electronics. Based on this information, the
radiation response is going to be related to the sensitivity of each individual pixel, the
gain of its corresponding preamplifier channel, etc. Thus, it is possible to generate a flat
field correction protocol to allow for the small variations of the overall detector system
response on a pixel by pixel basis.
This equalization process adjusts the detector values and the detector configuration to
generate a flat response output from the detector assuming a uniform beam is incident on
the detector. Figure 4.3 shows the schematic of the equalisation setup.
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Figure 4.3. The schematic of the equalisation setup
The MP512 was placed at a depth of 10 cm in the solid water phantom with 10 cm back
scattering. 200 MUs were delivered to a 20 x 20 cm2 field size at SSD of 100 cm. The flat
field correction can be calculated following equation (4.1), (4.2) and (4.3) [228], [229].
The response of the MP512, vector Xi, for all pixels is considered the same. The average
response from all channels was calculated (X). The equalization factor vector, Fi, was
then

𝑋

𝐹𝑖 = (𝑋)𝑖
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And the equalised detector response for each pixel, Xeq-i, was then

𝑋

𝑋𝑒𝑞−𝑖 = 𝐹𝑖
𝑖

(4.2)

The detector uniformity can be calculated by the equation (4.3) where Xcen is the vector
at a central pixel which is located at row 11, column 12.

𝑋% =

𝑋𝑒𝑞−𝑖 −𝑋𝑐𝑒𝑛
𝑋𝑐𝑒𝑛

(4.3)

The variation in the response of all 512 detectors relative to the average response can then
be calculated before and after flat field correction for any beam energy desired.

4.2.3 Output Factor measurement

The output factor (OF) presents the dose rate and the amount of radiation exposure
produced by a treatment machine. It can be defined as the ratio of the dose per monitor
unit (MU) for a given field size to the reference field size [230]. The reference field size
in this study is 10x10 cm2 at the source to surface distance (SSD) of 90 cm [13]. Figure
4.4 shows the MP512 output factor measurement setup.
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Figure 4.4. The output factor measurement setup of Magic Plate 512 with various
detector air gaps.

The MP512 was placed on solid water phantom at the depth of 10 cm with an additional
10 cm of solid water to act as back scatter and was aligned at the centre of the beam. The
OF was measured for square fields ranging from 0.5 x 0.5 cm2 to 10 x 10 cm2 and was
deduced based on the response of the central pixel which is located at row 11 and column
12. The measurements were performed in 6 and 10 MV photon beams with a 600 MU/min
dose rate. 100 MU was delivered with open field MLCs. The size of the air gap above
MP512 detector was set at 0.5, 1.0, 1.2, 2.0 and 2.6 mm. The measurements were taken
three times at least and directly compared with EBT3 films and MOSkin response under
the same conditions.
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4.2.4 Percentage Depth Dose (PDD) for 6 MV and 10 MV photon beam

The PDD profiles were acquired using different air gap sizes upstream of MP512 detector.
The air gaps used for the 6 MV photon beam was 0.5 mm and 2.6 mm, and for the 10 MV
photon beam they were 1.2 mm and 2.6 mm. The MP512 was placed perpendicular to the
direction to the central axis (CAX) of the beam at an SSD of 100 cm for field size of 2 x
2 cm2, 5 x 5cm2 and 10 x 10cm2. The PDDs were obtained by scanning the MP512 from
a depth of 0.5 cm to 10 cm. The PDDs were normalized to the MP response at the depth
of dmax for all photon energies investigated. The dmax for 6 MV and 10 MV photon beam
is 1.5 cm and 2.1 cm, respectively. For all irradiation geometries, 100 MU was delivered
with a 600MU/min dose rate. The PDD measured by the MP512 with different air gaps
were directly compared with the PDD response measured by an original Markus IC
(PTW, Freiburg, Germany, model: N23343) for field sizes of 10 x 10 cm2 and 5 x 5 cm2.
For the small field size of 2 x 2 cm2 the results were compared to the EBT3 films to gain
an understanding of the impact of any volume averaging effects as well as any beam
perturbation effects from the window thickness of the ionisation chamber [231].

4.2.5 Wedge beam profile measurements for 6 MV photon beam
Wedge beam profile measurements were done using a 5 x 5 cm2 radiation field size which
was the smallest field the Linac can generate for enhanced dynamic wedge (EDW) field.
The EDW profiles were produced by varying the jaw position and/or the output rate
during the treatment dose delivery. The EDW of 15°, 45° and 60° were used for this study
and generated by Varian Linac (model 2100IX). The MP512 was placed at a depth of 10
cm in solid water phantom and aligned on the central axis of the beam. A 100 MU was
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delivered at 100 cm SSD for each wedge angle for a 6 MV photon beam. The air gap sizes
of 0.5 mm and 2.6 mm were used as part of this particular study.
To convert the MP512 response to dose (Gy) the MP512 responses were multiplied by
the calibration factor (CF). To obtain the CF, the MP512 was placed at a depth of Dmax,
the dose-maximum depth, and exposed to a 10x10 cm2 field size at the 100 cm SSD. The
calibration factor can be calculated using equation (4.4) below where “MU” is the known
MU delivered to the MP512 and “MP” is the average response of the central pixel of the
MP512.

𝐶𝐹 =

𝑀𝑈
𝑀𝑃

(4.4)

The dose measured by the MP512 was directly compared with the independently
calibrated EBT3 film response measurements made under the same conditions

4.2.6 Percentage Depth Dose for electron beams

The PDD measurements in electron beam fields were performed in the same solid water
phantom. The SSD was set to 100 cm. A 10 x 10 cm2 applicator and a standard cerrobend
cutout of 10 x 10 cm2 were used to define the electron field dimensions. The MP512 was
placed in the solid water phantom and aligned at the centre of the beam. The
measurements were performed at a depth of 0.5 cm to 10 cm in a solid water phantom.
The results were investigated for 6 MeV, 12 MeV and 20 MeV electron beams with air
gap sizes of 0.5 mm and 2.6 mm. All measurements were performed at least three times.
The results were compared with the PDD measured by Markus IC.
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4.2.6.1 Use of plastic phantom for depth dose measurement
correction

The IAEA has recommended that to measure a central-axis depth dose for electron beam
in a plastic phantom, the dosimeter reading at each depth must be scaled because for the
electron beam, the water-to-air stopping power ratio, Sw,air, changes rapidly with depth
[232]. In this part of the study, the electron beam depth dose measured by an ion chamber
was followed using the code of practice for radiotherapy dosimetry, TRS-398 [75].
In this study, the solid water phantom; RMI-457 was used for the measurements. The
equivalent depth in water, Zw, can be calculated by equation (4.5) below.

𝑍

𝑍𝑊 = 𝐶𝑃𝑙
𝑃𝑙

(4.5)

Where Zpl is the depth in the solid water phantom (cm) multiplied by Ppl.

Ppl is the density of the plastic, Ppl for the solid water (RMI-457) is 1.030 gcm-3. Cpl is the
depth scaling factor, Cpl for the solid water (RMI-457), which is 0.949 gcm-3.

The reading from the Markus IC was multiplied by the fluence-scaling factor, hpl, for
certain plastics to find the equivalent reading at Zref in water (MQ) as presented in equation
(4.6).

𝑀𝑄 = 𝑀𝑄,𝑝𝑙 ℎ𝑝𝑙

(4.6)

Where MQ, pl is the IC reading at the scaling depth in water (Zw), and the hpl is the fluence
scaling factor. The fluence scaling of the solid water (RMI-457) is 1.008.
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All IC current, MQ, was then multiplied by the appropriate stopping-power-ratio, Sw,air, at
each depth. Table 4.1 summarizes the stopping-power-ratio as a function of beam quality
R50 (g cm-2) and relative depth Z/R50 in water of each depth use for electron beam PDD
measurement is this study [75].

Table 4.1. The water-to-air to stopping-power-ratio for 6 MeV, 12 MeV and 20 MeV as
a function of beam quality R50 and relative depth Z/R50.
6 MeV
Depth (cm)
Sw, air
0.50
1.0500
0.70
1.0600
1.00
1.0700
1.20
1.0800
1.30
1.0800
1.50
1.0900
2.00
1.1100
2.30
1.1300
2.50
1.1400
3.00
1.1700
3.50
1.1800
5.00
1.2700
*R50 = R50 in water x Cpl

12 MeV
Depth (cm)
0.50
1.00
2.00
2.50
2.90
3.90
4.50
5.00
5.50
6.50
10.00
˗

Sw, air
1.0000
1.0100
1.0400
1.0500
1.0600
1.0900
1.1100
1.1200
1.1400
1.1700
1.3180
˗

20 MeV
Depth (cm)
0.50
1.00
2.00
2.60
4.00
6.00
6.10
7.00
7.50
9.00
10.00
˗

Sw, air
0.97
0.98
0.99
1.00
1.02
1.06
1.06
1.08
1.09
1.13
1.16
˗

**R50 of 6 MeV, 12 MeV and 20 MeV = 2.18 gcm-2, 4.65 gcm-2 and 7.97 gcm-2

4.3 Results and discussion
4.3.1 Output factor for 6 MV and 10 MV photon beam

The average of the four central pixels of the MP512 was evaluated for the OF
measurements. The MP512 uncertainty was found to be 0.2% (1 s.d.) for all
measurements. Figure 4.5 and Figure 4.6 show the OF measured by the MP512 at a depth
of 10 cm in solid water phantom for different air gaps above detector compared to the
EBT3 film and MOSkin (with no air gap above them). The response is normalized to the
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response measured in a 10 x 10 cm2 field size, for 6 MV and 10 MV, respectively. Figure
4.5 illustrates that at small field sizes the OF measured with the MP512 reduces with
increasing detector air gap. A significant effect of the air gap size has been observed for
a 0.5 and 1 cm2 field size. The air gap has negligible effect for field sizes larger than 4 x
4 cm2 for the air gap of 0.5 mm, 1 mm and 1.2 mm above the detector. the MP512 with
the air gap of 0.5 mm shows good agreement to the output factors measured with the
EBT3 film and MOSkin within ±2% (1 standard deviation) for very small field sizes up
to 3cm2 and not more than 3 % for 3-5 cm2 and no difference with field size increasing
(zero for 10x10 cm2 ).
As expected, for small radiation fields of 0.5 x 0.5 cm2 and 1 x 1 cm2 the output factor
reduces with the air gap increasing for the 10 MV photon beam as presented in Figure
4.6. The MP512 response with air gap size of 1.2 mm best matched the output factors
measured with the EBT3 and MOSkin within ±2% for field sizes smaller than 4x4 cm2 (1
standard deviation) for 10 MV photon beam fields.

With increasing of radiation field size, the effect of an electronic disequilibrium produced
by air gap is diminishing. It is explained by the fact that laterally scattered radiation
dominate response of the MP512 in comparison with lack of secondary electrons
generated in an air gap. It is confirmed by experimental results. At field size of 0.5 x 0.5
cm2 and 1 x 1 cm2, the percentage different between MP512 and EBT was more than 12%
when the air gap size increased from 0.5mm to 2.6 mm. Similar behavior was observed
when compared with the MOSkin detector. While at field sizes 4x4 cm2 the output factor
measured with MP512 difference of the output factors measured by ETB3 and MOSkin
is about only 5-7% when the air gap size increased from 0.5 mm to 2.6 mm and is not
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changing at all for 10x10 cm2 filed size. Based on these studies the optimal air gap was
selected to match OF measured with MP512 to the film.
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Figure 4.5. Field size response of the MP512, EBT3 film and MOSkin for a 6 MV
photon beam, normalized to the response measured in a 10 x 10 cm2 field size at a depth
10 cm in a solid water phantom for different air gaps of (a) 0.5 mm, (b) 1.0 mm, (c) 1.2
mm, (d) 2.0 mm and (e) 2.6 mm
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Figure 4.6. Field size response of the MP512, EBT3 film and MOSkin for a 10 MV
photon beam normalized to the response at 10 x 10 cm2 field size at a 10 cm depth in a
solid water phantom and air gap of (a) 0.5 mm, (b) 1.0 mm, (c) 1.2 mm, (d) 2.0 mm and
(e) 2.6 mm.

4.3.2 Percentage Depth Dose (PDD) for 6 MV and 10 MV photon beams

Figure 4.7 and Figure 4.8 present the PDD measured with the MP512 in a solid water
phantom for 0.5 mm and 2.6 mm air gap upstream of the detector for different field sizes
in comparison with a Markus IC for 6 MV and 10 MV photon beams, respectively. All
reading from the Markus IC has been corrected for over-response by using the corrected
factor is given by Chen et al [210]. Similar results were observed for the photon beam
PDD measurements. As the size of the air gap above the detector increased, the PDD
demonstrated a detectable decrease field size of 5 x 5 cm2 and 10 x 10 cm2.The PDD for
2 x 2 cm2 field was within ±3% (1 SD) of the EBT3 for both photon energies. For field
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size 5x5 cm2 and 10x10 cm2, the PDD measured with the MP512 is within ±1.6% (1 SD)
and ±1.5% (1 SD) of that measured using a Markus ionisation chamber for 6 and 10 MV
fields respectively.
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Figure 4.7. PDD measured with 0.5 mm and 2.6 mm air gap above the MP512 of 6 MV
photons in comparison with an ionisation chamber and EBT3 film for field sizes of (a)
10x10 cm2, (b) 5x5 cm2 and (c) 2x2 cm2.
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Figure 4.8. PDD measured with 1.2 mm and 2.6 mm air gap above the MP512 of 10
MV photons in comparison with an ionisation chamber and EBT3 film for field sizes of
(a) 10x10 cm2, (b) 5x5 cm2 and (c) 2x2 cm2.

4.3.3 Wedge beam profile for photon beams

Figure 4.9 shows the beam profile measured in the wedge direction at a depth of 10 cm
for the MP512 with a 0.5 mm and 2.6 mm air gap above the detector in comparison with
EBT3 film. The EDW dose profile matches well with the EBT3 for the air gap of 0.5
mm, within ±1% (1 SD), except at the toe and heel region where the difference was within
±3% (1 SD) for all wedge angles. The difference increases with an increase in the air gap
size. For the 2.6 mm air gap, the difference on the heel side was observed to be about
±10% (1 SD). The Wedge profiles show that if only the flattened area of the field is
considered, the maximum difference between profile and the EBT3 film is within ±1%
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for small air gap size 0.5mm for all wedges angles. There is a significant difference in the
shape of the wedge profile when a 2.6 mm air gap size is used.
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Figure 4.9. Wedge beam profiles measured with the MP512 with different air gaps in
comparison with those measured using EBT3 film at a depth of 10 cm for 6 MV photon
beam with a field size of 5x5 cm2 (a) 15° Wedges, (b) 45° Wedges and (c) 60° Wedges.
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4.3.4 Percentage depth dose for electron beams

The PDD measured by the MP512 in electron beams demonstrated no significant effect
with increasing air gap above the MP512 for all energies. The correction for use of the
plastic phantom for electron depth dose distributions follows the TRS398 instruction [75].
The results for both 0.5 mm and 2.6 mm air gap are within ±3% (1 SD) of similar
measurements made using the Markus IC and are shown in Figure 4.10.
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Figure 4.10. PDD measured with MP512 and 0.5 mm and 2.6 mm air gap upstream of
the detector on electron beams for a field size 10 x 10 cm2 in comparison with a Markus
ionisation chamber in a solid water phantom for electron beam energies of (a) 6 MeV,
(b) 12 MeV and (c) 20 MeV.
73

Chapter 4: Optimization of the air gap upstream the MP512 when operate in dose mode

4.4 Conclusion
The MP512 response with different air gaps upstream of the detector in a solid water
phantom have been investigated in both photon and electron fields. The results obtained
in this study show that the air gaps cause a measurable dose reduction for small radiation
field sizes due to the loss in electron equilibrium. Based on these findings, we have tried
to optimize the air gap size for a monolithic diode array detector, MP512 for both photon
and electron fields. The studies confirmed that the MP512 monolithic diode array is
suitable for QA of small fields in a phantom. The small air gap of 0.5 mm and 1.2 mm is
the best air gap for small field dosimetry in 6 MV and 10 MV photon beams, respectively.
However, the effect of air gap on electron beams is not significant due to electronic
equilibrium conditions being fully established and maintained.
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CHAPTER 5
DOSIMETRIC IMPACT OF MAGIC
PLATE512 OPERATING IN TRANSMISSION
MODE ON CLINICAL PHOTON BEAMS
This chapter describes, from a dosimetry perspective, the impact of the monolithic silicon
detector, MP512 when operating in transmission mode, so named MP512 T. In particular
I studied the effect of the MP512T on the surface dose as a function of different field sizes
and the specific MP512T detector mounting position between the solid water phantom
and the Linac head. As part of my work the unique transmission factor for the MP512T
and the PCB were evaluated.

5.1 Introduction
The Magic Plate 512 has been previously reported in dose mode measurements for
SRS/SBRT verification [168]. Further investigation, including the effect of the air gap
size above the detector, has been discussed in the previous chapter of this thesis. The
MP512 with the difference in the detector packaging called MP512T (described in
Chapter 3) has been designed to be used as a transmission detector for real time dose
reconstruction measurements.
Any radiation beam perturbation, in particular any surface dose increase, is of significant
interest due to its impact on clinical outcomes associated with transmission type detectors
[156], [162], [164], [233]. As a transmission-type detector, a detailed study for the
MP512T is therefore required to assess its future clinical suitability.
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The MP512T, in contrast to the previously characterized transmission magic plate
detector called MP121 [234] is essentially different in design and has a much improved
spatial resolution. The details of the MP121 were described in Chapter 2. The MP512T
is a monolithic silicon detector that can lead to different perturbation of the skin dose in
megavoltage photon fields. Additionally, the MP121 was characterized only when the
detector was attached to the Linac head. Unlike the MP121, the MP512T system is
designed to be placed at various distances between the Linac head and the solid water
phantom surface. Therefore, it is important to investigate, understand and quantify any
effect on the skin dose of the different MP512T detector operating positions.
This chapter will investigate the Magic Plate 512T when operating in transmission mode,
on beam perturbation, in particular on the surface dose and beam transmission with
different field sizes and positions between the solid water phantom and Linac head.

5.2 Materials and Methods

5.2.1 A concept of transmission movable high resolution

Figure 5.1. The concept of using a transmission monolithic silicon detector providing a
flexible resolution by using a variable detector to surface distance, Dsd, by moving the
detector between the Linac head and the patient. Figure 5.1 shows a concept of the
transmission monolithic silicon detector providing flexible spatial resolution by changing
detector distances from the solid water phantom (Dsd). Moving the detector along the
beam axis between the patient surface and the Linac
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head enables the effective spatial resolution of the detector monitoring the radiation field
to change due to the beam divergence. As the tumour size decreases, moving the detector
close to the patient provides a higher effective spatial resolution while allowing the
monitoring of the entire treatment field.

Figure 5.1. The concept of using a transmission monolithic silicon detector providing a
flexible resolution by using a variable detector to surface distance, Dsd, by moving the
detector between the Linac head and the patient.

The proposed movable transmission, high effective spatial resolution silicon monolithic
detector has another advantage in comparison with the currently used transmission
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detectors mounted on the Linac head. By moving the detector below the Linac head, the
contribution of electrons scattered from the head of the Linac on the response of the
detector is minimized, and the detector response is mostly driven by the photon energy
fluence, which should simplify the 3D dose reconstruction algorithm.

5.2.2 A movable stand detector holder

The MP512T detector was mounted on a movable stand in order for the detector to be
positioned between the Linac head and the solid water phantom at any distance from the
phantom surface. The movable stand is made from a PMMA plastic. The holder arms are
40 cm in length and can be adjusted to fit the detector assembly up to a width of 45 cm.
The holder has the capability of moving in the vertical direction. When placing MP512T
on the movable stand holder, only the detector itself was irradiated. Figure 5.2 shows the
movable stand and its geometry.
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Figure 5.2. The movable stand and its geometry

5.2.3 The influence of MP512T on the surface dose

To obtain the surface dose, a Markus ionisation chamber (PTW, Freiburg, Freiburg,
Germany, model N23343) was positioned at the surface of the solid water phantom at
central axis (CAX) corresponding to the isocentre, with 100 cm SSD. The back scattering
solid water phantom was 10 cm thick. The IC was read out by PTW UNIDOS model
T10002-20713 electrometer. All readings from the Markus IC have been corrected for
over response by using the corrected factor given by Chen et al. [210] described in
Chapter 3.
The perturbation of the surface dose was reported as a percentage difference of the surface
dose measured with MP512T in a beam to open field. Both MP512T and the Markus IC
were aligned at the centre of the beam. All measurements were performed using a 6 MV
photon beams from a Varian linear accelerator (Model 21XI). For each measurement, a
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200 monitor unit (MU) was delivered. The MP512T distance from the solid water
phantom surface was varied from 0.3 cm to 24 cm. The measurements were carried out
for irradiation field sizes (IFS) of 5 x 5 cm2, 8 x 8 cm2 and 10 x 10 cm2 with the MLC
matched with the Linac jaws. The measurement setup is shown in Figure 5.3.

(a)

80

Chapter 5: Dosimetric impact of MP512 operating in transmission mode on clinical
photon beams

(b)
Figure 5.3. The measurement setup (a) with and (b) without MP512T in a beam.

The radiation field size is defined at the SSD of 100 cm. Thus, the effective irradiation
field size at MP512T position depends on the distance away from the solid water phantom
and ranges about from 3 x 3 cm2 to 7 x 7 cm2 at the Linac head placement.
Table 5.1 presents the actual field size on MP512T detector at various distances from the
solid water phantom surface.
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Table 5.1. The field size of the MP512T detector at various distances from the solid water
phantom surface.

Field size (cm2)

Dsd(cm)
0.00

5.00

8.00

10.00

0.30

4.99

7.98

9.97

4.50

4.78

7.64

9.55

9.00

4.55

7.28

9.10

13.50

4.33

6.92

8.65

18.00

4.10

6.56

8.20

20.00

4.00

6.40

8.00

22.00

3.90

6.24

7.80

24.00

3.80

6.08

7.60

To examine the reproducibility of the Markus IC the readings were acquired three times
at least under the same conditions. The detector measurement uncertainty was found to
be ± 0.2% (1 s.d.).

5.2.4 The influence of the MP512T on the surface dose when placed face up
and face down

The influence of the MP512T on the surface dose when placed at different Dsd face up
and face down were evaluated. The set of measurements as section 5.2.3 was repeated.
Figure 5.4 shows the schematic of the surface dose measurement setup with MP512T in
a beam (a) face up; (b) face down. For each position and field size, the readings are
obtained at least three times, and the average was calculated.
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(a)

(b)

Figure 5.4. Schematic of MP512T (a) face up and (b) face down

5.2.5 Effect of Printed Circuit Board on MP512T surface dose measurement

To evaluate the effect of the 0.5 mm thick printed circuit board (PCB) only on the surface
dose, the PCB without the mounted silicon detector was placed on the movable stand.
The surface dose measurements were performed using the Markus IC in a solid water
phantom for open fields and with the PCB in the beam similar to that described in section
5.2.3.

5.2.6 The transmission factor measurement

The transmission factor (TF) of the MP512T and the PCB were investigated by measuring
a ratio of the doses at dmax corresponding to the filed 10 cmx10cm, i.e.at depth in a
phantom 15 mm depth with and without MP512T in a beam for radiation field size 5x5
cm2, 8x8 cm2 and 10x10 cm2 and SSD of 100 cm for a 6 MV photon beam. The MP512T
was placed in the beam at different Dsd ranging from 0.3 cm to 24 cm. A Farmer IC
(Model 2571A) was used for dose measurements. The same set up was repeated at a depth
of 10 cm and a source axial distance (SAD) of 100 cm for a 6 MV photon beam.
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5.3 Results
5.3.1 The influence of MP512T on the surface dose

Figure 5.5 shows the percentage difference of surface dose with and without MP512T in
the beam path as a function of field size and distance from the solid water phantom
surface. The percentage difference was calculated follow equation (5.1).

with MP512−without MP512

%Diff = (

without MP512

) 𝑥100 ……………………… (5.1)

The maximum difference of surface dose was nearly 30% (1 standard deviation), and this
was found at the distance of 0.3 cm especially in the large 10 x 10 cm2 field. The
difference in surface dose decreased with increasing distance of MP512T from the solid
water phantom surface. At Dsd>18 cm the difference was less than 5% (1 standard
deviation) for all IFSs. At a small field size of 5 x 5 cm2, the percentage difference was
within ±1 % (1 standard deviation).
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Figure 5.5. The percentage difference of surface dose with and without MP512T in a
beam as a function of distance of MP512T from the phantom surface and field size for a
6 MV photon beam.
The effect of MP on surface dose increasing is increasing with reducing distance between
Magic Plate and surface of the phantom. This explain by the fact that surface dose has
three component one is due to electron contamination originated from scattered electrons
in a linac head, second is from electron generated in air between linac head and the
phantom surface and third due to electrons scattered from MP. On the other hand MP is
attenuated and scattered partially electrons originated above MP. Based on obtained
results attenuation of electrons by MP is not essential and combined effect is increasing
of the skin dose with reducing Dsd. It is explained by the fact that size of the photon field
incident on a MP is increasing with Dsd decreasing that is leading to more secondary
electrons originated from MP scattered to the phantom surface and surface dose
increasing respectively. This effect is more pronounced with filed size increasing that is
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reflected in a Fig 5.5. For Dsd larger than 18 cm the effect of electron scattered from the
MP is not essential in comparison with other two electron components as a photon filed
size seeing by MP is small was observed.
5.3.2 The influence of the MP512T on the surface dose when placed face up
and face down

Figure 5.6 shows the percentage difference of surface dose when MP512T is placed faceup and face-down at various distances from the phantom surface and different IFSs. The
percentage difference was calculated follow equation (5.2).

𝑀𝑃512 𝑓𝑎𝑐𝑒 𝑑𝑜𝑤𝑛−𝑀𝑃512 𝑓𝑎𝑐𝑒 𝑢𝑝

%Diff = (

𝑀𝑃512 𝑓𝑎𝑐𝑒 𝑢𝑝

) 𝑥100 ……………….(5.2)

The difference was within 2.5 % (1 standard deviation) for all distances and field sizes.
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Figure 5.6. The percentage difference of surface dose when MP512T is face-up and
face-down in the beam as a function of distance from the phantom surface and field size
for a 6MV photon beam.
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Difference in skin dose changing for face down and face up configuration has tendency
of slight skin dose increasing for face down configuration for smaller fields when more
electron scattered down from the silicon MP not attenuated by PCB than in case of face
up configuration. For 10cmx10 cm field size in MP plane is always larger than size of the
silicon MP for all Dsd and total electron scattering towards the phantom surface do not
make such difference as scattering from PCB outside from the silicon MP is the same for
both configurations
5.3.3 The effect of printed circuit board on the surface dose

Figure 5.7 shows the percentage difference of the surface dose measured with and without
the PCB in the beam. The percentage difference was calculated follow equation (5.3).

%Diff = (

𝑤𝑖𝑡ℎ 𝑃𝐶𝐵−𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑃𝐶𝐵
𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑃𝐶𝐵

) 𝑥100…… ……………….(5.3)

Similarly, to Figure 5.5, the surface dose difference increased when the PCB was closer
to the phantom surface. At PCB distances of more than 18 cm, the percentage difference
is close to zero for all IFSs. At a PCB distance of 0.3 cm, the surface dose increased by
about 15% (1 standard deviation) for all IFSs.
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Figure 5.7. The percentage difference of the surface dose with and without the PCB in a
beam as a function of distance of the MP512T from the phantom surface and for various
field sizes in a 6 MV photon beam.
The effect of PCB only of surface dose increasing with Dds decreasing for all field sizes
is explained as in 5.3.1
5.3.4 The transmission factor measurement

At the 6 MV dmax depth, the relative dose difference increases slightly with decreasing of
the distance (from 18 cm to 0.3 cm) between the phantom surface and the MP512T (or
blank PCB). The TF was calculated follow equation 5.4.

𝑤𝑖𝑡ℎ 𝑀𝑃512

TF = (𝑤𝑖𝑡ℎ𝑜𝑢𝑡 𝑀𝑃512)………………………………..(5.4)

For Dsd <18cm the TF changes by 1.5-2.0 % (1 standard deviation) and 0.5% (1 standard
deviation) for MP512T and PCB respectively for all IFSs and all distances above 18 cm
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is close to 1. These results are presented in
Table 5.2. Similar behaviour of the transmission factor is observed at a depth of 10 cm as
shown in

Table 5.3.

Table 5.2. Measured TF at dmax for 6 MV photon beam, SSD =100 cm. The TF is
presented separately for various distances and IFSs for MP512T and the PCB
MP512T

PCB

Dsd (cm)
5x5 cm2

8x8 cm2

10x10 cm2

5x5 cm2

8x8 cm2

10x10 cm2

0.30

1.0130

1.0151

1.0198

1.0055

1.0058

1.0067

4.50

1.0120

1.0141

1.0186

1.0051

1.0054

1.0062

9.00

1.0096

1.0104

1.0133

1.0032

1.0038

1.0046

13.50

1.0040

1.0047

1.0069

1.0018

1.0026

1.0029

18.00

0.9985

0.9993

0.9996

0.9980

0.9982

0.9989

20.00

0.9981

0.9990

0.9988

0.9978

0.9982

0.9990

22.00

0.9975

0.9977

0.9991

0.9980

0.9980

0.9980

24.00

0.9971

0.9980

0.9985

0.9976

0.9975

0.9973
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Table 5.3 Measured TF at a depth of 10 cm for 6 MV photon beam, SAD =100 cm. The
TF is presented separately for various distances and IFSs for MP512 and the PCB
MP512T

PCB

Dsd (cm)
5x5 cm2

8x8 cm2

10x10 cm2

5x5 cm2

8x8 cm2

10x10 cm2

0.30

1.0190

1.0200

1.0220

1.0122

1.0129

1.0137

4.50

1.0182

1.0190

1.0216

1.0120

1.0124

1.0131

9.00

1.0132

1.0147

1.0159

1.0085

1.0099

1.0105

13.50

1.0069

1.0076

1.0092

1.0059

1.0063

1.0062

18.00

1.0022

1.0032

1.0037

1.0018

1.0024

1.0030

20.00

1.0020

1.0022

1.0020

1.0012

1.0019

1.0020

22.00

1.0010

1.0012

1.0015

0.9991

0.9993

0.9994

24.00

0.9993

0.9997

1.0011

0.9991

0.9989

0.9992

5.4 Discussion
Quality Assurance (QA) in advanced treatment radiotherapy techniques such as SRS and
SBRT is complicated due to the small field delivery using IMRT or VMAT for SBRT
and high definition of the MLCs and small cones for SRS. Thus, the treatment verification
requires high spatial resolution QA tools, which accurately provide the relevant dose
information in real-time during the treatment delivery for each gantry angle. Thus, a new
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QA device, the monolithic silicon pixelated detectors MP512T was introduced. The
MP512T provides a variable, yet high, effective spatial resolution due to its ability to be

placed at different positions in the beam between the Linac head and the patient. In this
way, the beam projection at any depth is within the area of silicon detector or PCB and
avoids the effect of attenuation by a PMMA frame (Figure 5.1). These detectors allow
one to obtain a variable effective spatial resolution from 2 mm to 4 mm depending on the
position of the detector on the beam axis relative to the Linac head. Another advantage
of this approach is the reduction of the contribution of scattered electrons from the Linac
head to the response of the transmission detectors. The thin silicon substrate 0.45 mm and
0.5 mm PCB is a prerequisite to minimize any beam perturbation.
It was demonstrated that the MP512T and the PCB alone increases the surface dose due
to Compton electrons originating from the silicon and the PCB. The partial contribution
of the PCB alone led to the rise in the surface dose of about 60% compared to the increase
in the surface dose from MP512T (Figure 5.5 and Figure 5.7). Taking into account that
the Compton electrons, in this case, are mostly of a MeV energy range, it suggests that
an opening or recess in the PCB under the silicon monolithic detector active area is
recommended to further reduce the skin dose excess by a factor of two for all the IFSs
considered. We also demonstrated that in the face-up or face-down orientation the
MP512T makes only a 2% (1 standard deviation) difference in the excess surface dose
(Error! Reference source not found. 5.6) and will be close to zero if an opening or
recess is introduced in the PCB substrate. A thin light protective coating should be
introduced above the silicon detector to avoid stray light influencing the detector
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response. It can easily be achieved by adding a black filler to the thin layer of resin
protecting the silicon detector.
The transmission coefficient of the MP512T measured at dmax 15 mm is close to 1 with a
deviation of about 1.010-1.020 with decreasing distance between the MP512T and the

phantom surface below 18 cm. The effect of the MP on dose modification at depth 15mm
and 100 mm was less than 1% for Dsd large than 13.5cm that is within dose modification
tolerance and less than 2.2% for all other Dsd (see Tables 5.2 and 5.3). It is recommended
for in vivo application not to use Dsd less than 13.5 cm that is safe in terms of avoiding
collision with the patient body and for in a phantom QA to introduce correction to
measured dose in case of measured dose based on transmission MP for Dsd less than
13.5cm. Providing an opening in the PCB under the silicon monolithic detector will make
the transmission coefficient closer to 1 for any placement of the proposed transmission
detectors between the patient and Linac head.

5.6 Conclusions
The MP512T detector used as a transmission detector with a variable spatial resolution
of up to 1 mm at variable positions between the Linac head has been introduced. The
MP512T is characterized by its minimal beam perturbation. Spatial resolution in
dosimetry of the small photon beams can be improved by moving the MP512T along the
beam axis with the best spatial resolution reported when the detector is closest to the
surface of the patient. Further reduction of the skin dose excess can be achieved by
reducing the silicon substrate thickness to 0.3 mm and utilizing a drop-in packaging style
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for the detector [228] on the PCB with the recess accommodating the monolithicsilicon
detector.
The mechanical realization of the proposed transmission detector in a clinical scenario is
still to be done but will be straight forward and will be realized by a telescopic jig attached
to the Linac head slot, and wireless reader developed at CMRP similar to other
transmission [156], [160], [164], [235].
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CHAPTER 6
QA OF AN INTENSITY MODULATED
RADIOTHERAPY CLINICAL SCENARIO
USING THE MP512T WITH VARIABLE
SPATIAL RESOLUTION
This chapter extends the work of the previous chapter. The MP512T placed on the
movable stand position between the Linac head and the solid water phantom will
completely use with the data acquisition system. This chapter discusses the correlation of
transmission mode response (TM) and dose mode response (DM) of the MP512T for dose
prediction at dmax.

6.1 Introduction
The quality assurance (QA) of SRS and SBRT treatments are complex due to the use of
small field delivery techniques using IMRT or VMAT for SBRT employing either high
definition MLCs and/or small cones in the case of SRS, [37], [41], [177], [236], [237].
Many devices have been developed for pre-treatment verification such as two-dimensional
(2D) detector arrays based on ionisation chamber (IC) and semiconductor detectors [59],
[117], [122], [238]–[240].
There is a considerable demand for real-time dose delivery verification. Such QA
technology enables a real-time detection of major errors in the delivered dose [62]. In
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particular Electronic Portal Imaging Devices (EPIDs) have been used for real-time
verification. The method can be used for fixed gantry IMRT treatment, and it is not yet
available for dynamic arc treatment [153], [154], [241].
A real-time dose measurement can also be carried out using transmission-type detectors
where the detector is positioned in the photon beam between the Linear Accelerator
(Linac) head and the patient. Commercially available transmission-type detectors such as
the David system (PTW-Freiburg, Germany), Dolphin system (IBA Dosimetry,
Germany), the Compass system (IBA, Dosimetry), the Delta4 (ScandiDose, Sweden), and
the integral quality monitoring system (IQM) are based on pixelated ionisation chambers
and semiconductor diode arrays. The use of these systems result in a change of beam
characteristics and lead to an increase in the surface dose [156], [157], [160], [162], [164].
Although, some transmission QA dosimetry devices are available and perform well for
larger fields, their spatial resolution and resulting perturbation of the radiation field due to
their design, limits their utilization as a part of a routine clinical practice for small field
real-time treatment verification.
The aim of this chapter is to investigate the possible correlation of the MP512T when
using it in transmission mode (TM) and dose mode (DM) for different Dsd and treatment
field sizes. The dose at dmax for regular field sizes and intensity modulated treatment fields
has therefore been calculated using a direct linear correlation found between the MP512
DM and TM measurements.
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6.2 Material and methods

6.2.1 Experimental Setup

The MP512T was placed on the movable stand made form a PMMA plastic, as described
in chapter 5, so the detector can be positioned between the Linac head and the solid water
phantom at various distances from the phantom surface. Compared to other transmission
detectors where the detector is mounted on the Linac head, the use of a movable
transmission monolithic detector that can be mounted away from the Linac head reduces
electron scatter, and therefore the photon energy fluence can be measured more accurately.
The changes in the surface dose observed when placing the MP512T in the air between
the Linac head and the phantom has been discussed in the previous chapter. The MP512T
detector produced only minimal perturbations and was fully transparent for 6 MV photon
beams when placed at a Dsd of ≥18 cm above the phantom. The observed surface dose
increased by about 5% and the difference was close to zero for small field sizes of less or
equal to 5x5 cm2. The transmission coefficient of the MP512T measured at dmax is close
to 1.00 at Dsd of ≥18 cm, and with a deviation of about 1.010-1.020 when decreasing Dsd
below 18 cm.
The measurement setup is shown in Figure 6.1. The MP512T was connected to a Data
Acquisition System (DAQ) designed and built at CMRP. The system is based on a
multichannel electrometer chip. The DAQ consists of a Field Programmable Gate Array
(FPGA) that is read out in parallel by four analogue-to-digital converters (ADC). The
FPGA provides the clock and synchronization circuit for the DAQ allowing its
synchronization with the sync signal of the Linac. This guarantees that the charge
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generated in the detector is only acquired when the electron gun fires, avoiding any loss
of signal or unnecessary integration of dark current or electromagnetic induced noise. For
further details regarding the DAQ, refer to Fuduli et al.[201].

(a)
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(b)
Figure 6.1. (a) TM measurement setup of the MP512T allowing various distances
between the Linac head and solid water phantom surface, (b) DM measurement setup of
MP512T at a depth of dmax.

All experiments were performed on a Varian (Model 21XI) accelerator using 6 MV
photon beams. Since the MP512T has a thickness of 0.45 mm it is, therefore, possible to
operate it in both transmission mode and dose mode. The TM responses were measured
by placing the MP512T on the movable stand holder positioned at various Dsd ranging
from 0.3 cm to 24 cm. The MP512T was covered with a black plastic sheet, 80 µm thick
making the detector more light tight.
For the DM response, the MP512T was positioned in a homogenous solid water phantom
at depth of dmax (1.5 cm for 6 MV). As discussed in chapter 4, the air gap above the detector
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was set to 0.5mm so that electronic equilibrium is fully established for measurements of
output factors and PDD (within ±2%) [242], [243].
The TM and DM response measurements were performed for field sizes of 2 x 2 cm2,
3 x 3 cm2, 5 x 5 cm2, 8 x 8 cm2 and 10 x 10 cm2, and the treatment field size was defined
at a source to surface distance (SSD) of 100 cm. Each measurement was obtained
delivering 200 MU. All measurements were repeated in triplicate, and the resulting
standard error was calculated. To find the correlation between DM and TM measurements
the ratio of DM and TM, measurements were evaluated for each experimental setup.

6.2.2 Dose calculation for regular fields
The TM response was measured for regular field sizes of 1 x 1 cm2 and 4 x 4 cm2 at a Dsd
of 4 cm and 24 cm. The DM response at dmax was then calculated using the DM/TM
correlation shown in Equation 6.1. Note that these field sizes were not part of the
measurement set used to obtain the correlation. The field size of 1 x 1 cm2 lies outside the
measurement set and the expected response DM was extrapolated. While the 4x4 cm2 field
size lies between 2 of the field sizes of the measurement set and interpolation was used to
determine the expected DM response. The calculated doses were compared with the
measured dose determined using the MP512T detector placed in solid water at dmax.
6.2.3 Dose calculation in IMRT fields

To determine the delivered dose at dmax from MP512T transmission measurements,
intensity modulated fields used to treat a malignant base of skull chordoma were delivered
with the TM in place. The plan consists of 6 static fields and delivering a nominal dose
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1.8 Gy per fraction to the target volume (12.40 cm3). All IMRT fields were delivered with
the gantry set to 0° (gantry pointing vertically downward toward the phantom surface) for
a Dsd of 4 and 24 cm. A gamma evaluation with criteria of 1%/1mm, 2%/2mm and
3%/3mm was used to compare the measured dose distribution at dmax predicted from
transmission measurements to the dose computed at dmax using the TPS and the dose
measured by EBT film.

6.3 Results
6.3.1 The ratio of DM and TM response

The ratio of the DM to TM response for the central pixel of the MP512T at various Dsd
and field sizes is shown in Figure 6.2. The ratio of the DM to TM response for off-central
pixel including; -4mm, 4mm, -8mm, 8mm, -10mm, 10mm, -14mm and 14mm is shown
in Figure 6.3, Figure 6.4, Figure 6.5, Figure 6.6, Figure 6.7, Figure 6.8, Figure 6.9, and
Figure 6.10 respectively.
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Figure 6.2. The ratio of DM and TM response at central pixel measured by MP512T at
dmax for different Dsd, with constant irradiation field sizes.
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Figure 6.3. The ratio of DM and TM response at -4mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.
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Figure 6.4. The ratio of DM and TM response at 4mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.
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Figure 6.5. The ratio of DM and TM response at -8mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.
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Figure 6.6. The ratio of DM and TM response at 8mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.

2x2

1.40

3x3

5x5

8x8

10x10

1.20

DM/TM

1.00
0.80
0.60
0.40
0.20
0.00
0

5

10

15

20

Dsd (cm)
Figure 6.7.The ratio of DM and TM response at -10mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.
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Figure 6.8. The ratio of DM and TM response at 10mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.
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Figure 6.9.The ratio of DM and TM response at -14mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.
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Figure 6.10. The ratio of DM and TM response at 14mm off-central pixel measured by
MP512T at dmax for different Dsd, with constant irradiation field sizes.

The measurements points for each field size were fitted with a trend line using the least
squares method. Table 6.1 shows the resulting slope (M) and the DM/TM axis intercept
(BA0) for the central pixel of the MP512T at dmax for all field sizes. The uncertainty of the
calculated slope was within 0.21% (1SD) and 0.18% (1SD) for the intercept.

Table 6.1. Slope (M) and DM/TM axis intercept (BA0) at dmax for the central pixel of the
MP512T for various field sizes

Parameter

Field Size (cm2)
2

3

5

8

10

M

0.0199

0.0210

0.0180

0.0191

0.0201

BA0

1.1649

1.1437

1.0281

0.9686

0.9530
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From the results, the ratio of off-center pixels shows a similar behaviour to that of the
central pixel. The average difference between the central pixel slope and off-center pixel
slope was within ±1.79% (1 standard deviation).

6.3.2 The DM and TM correlation

As can be seen from Table 1, the slope M of the trend lines for DM /TM versus D sd only
weakly depends on the field size, and hence we have chosen to work with an average value
of the slope M. However, the same is not true for DM/TM axis intercept. Using an average
value, the slope M and the specific values for the DM/TM axis intercept in Table 1, one
can predict the dose at dmax using a transmission measurement as follows:

𝐷𝑀 = (𝑇𝑀)𝐷𝑠𝑑 (𝐵𝐴0 − 𝑀𝐷𝑠𝑑 )…………………………… (6.1)

Here M is the average slope for all field sizes, which was found to be 0.01960. DM/TM
axis intercept BA0 for an arbitrary equivalent field size as a function of the field area can
be found from the piecewise polynomial fit to the data shown in Figure 6.11.
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Figure 6.11. The relation of the DM/TM axis intercepts (BA0) as a function of field area
(A).

This data is well described by the following piecewise polynomial fits with each fit having
an R2 value of 1:

ìï
-0.00014214286× A2 - 0.00239214286× A+ 1.17674285714 for 0 cm2 ≤ A ≤ 25 cm 2
BAo = í
ïî 0.00001456410× A2 - 0.00282184615× A + 1.08954358974 for 25 cm 2 < A ≤ 100 cm2
(6.2)
The “kink behaviour” on Fig 6.11 is possibly due to the fact that all measurements were
related to Dmax depth 15 mm that is actually Dmax for 10cmx10cm field only. Further
investigation will be carried out for obtaining relation (6.1) for true Dmax for all filed sizes,
however it is outside of this thesis

107

Chapter 6: QA of an IMRT clinical scenario using MP512T with variable spatial resolution

6.3.3 Dose calculation for regular fields

For regular field size dose calculation, the responses at dmax were calculated when the TM
responses were measured at the detector to surface distances of 4 and 24 cm. The DM/TM
axis intercept BA0 for the 1x1cm2 and 4x4cm2 field size were obtained from

Equation 6.2. Note that the BA0 value for the 1x1cm2 field size results from extrapolation
while that for the 4 x 4 cm2 field size is obtained by interpolation as shown in Table 6.2.

Table 6.2. The calculated BA0 for field size (A) 1x1 cm2 and 4x4 cm2.
A (cm2)
1
4

BA0
1.2300
1.0900

The detector responses were multiplied by the calibration factor to convert the measured
detector signal to the absorbed dose (Gy). The dose calculation for regular fields is shown
in Table 6.3. For field size 1x1 cm2 the difference between measured dose and calculated
dose was -2.18% at 4cm Dsd and 0.63% and 24 cm Dsd. For field size 4x4 cm2 the
difference between measured dose and calculated dose was 0.93% at 4cm Dsd and 1.95%
and 24 cm Dsd.
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Table 6.3. The measured and calculated dose response of MP512 for central pixel at dmax
for field size 1x1 cm2 and 4x4 cm2
Dose response of MP512 at dmax (Gy)

Dsd
(cm)

Field Size 1x1 cm2

Field Size 4x4 cm2

Measured

Calculated

% Diff

Measured

Calculated

% Diff

4

0.8157

0.7979

-2.18

1.0040

1.0133

0.93

24

0.8157

0.8208

0.63

1.0040

1.0195

1.95

The absorbed dose for the 1x1cm2 field size was also compared with the dose measured
by EBT3, the difference being within ±1.73% for both detectors to surface distances.

6.2.4 Dose calculation for IMRT fields

For the IMRT dose calculation, the measurement and calculation were evaluated only at
the central fragment of the plan since the active MP512T detector area is 5.2 x 5.2 cm 2.
The plan consists of 6 delivery gantry angles. The equivalent field size (Aeq) for each
gantry angle was calculated using the standard equivalent square relationship shown in
equation (6.3) [244].

𝐴𝑒𝑞 =

2𝑥𝑦
𝑥+𝑦

…………………………………. (6.3)

DM/TM axis intercepts, BA0, for any square field were obtained from the second order
polynomial fits shown in Equation 6.2. Table 6.4 shows the equivalent field for each
gantry angle and the calculated BA0.
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Table 6.4. The equivalent field (Aeq) for each angle and the calculated BA0
Gantry (°)

Field Size (cm2)

Equivalent Field
size (cm2)

BA0

150
100
60
300
260
210

5x7.5
5x7.5
5x6
5x7.5
5x5.5
5x5.5

6x6
6x6
5.45x5.45
6x6
5.23x5.23
5.23x5.23

1.0068
1.0068
1.0186
1.0068
1.0233
1.0233

All calculated planar doses for each gantry at dmax were accumulated and compared with
the planar dose extracted from the TPS, the planar dose measured by EBT3 film and the
measured dose measured by MP512T at dmax by using Matlab.
Figure 6.12 shows the example the MP512T calculated planar dose at dmax from MP512T
transmission measurement Dsd = 4 cm compared to the dose from TPS with the gamma
evaluation of 3%/3mm using Matlab. All gamma evaluation is shown in Table 6.5. The
script used for gamma evaluation is in appendix B.
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Figure 6.12.The comparison of MP dose calculated when placing MP512T at Dsd = 4 cm
with the planer dose from TPS.
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Table 6.5. The gamma evaluation for IMRT plan dose calculation at Dsd of 4 and 24 cm
Gamma Evaluation
Dsd
(cm)

3%/3mm

2%/2mm

1%/1mm

MPcalTPS

MPcalEBT3

MPcalMPmeasured

MPcalTPS

MPcalEBT3

MPcalMPmeasured

MPcalTPS

MPcalEBT3

MPcalMPmeasured

4

98.14%

96.89%

99.79%

90.50%

92.00%

98.59%

62.20

69.40

99.40

24

97.22%

97.53%

99.69%

93.80%

93.80%

97.69%

59.00

71.00

99.00
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6.4 Discussion
In this chapter it was demonstrated that by placing the monolithic pixelated silicon
detector, MP512T at different positions between the Linac head and the solid water
phantom surface, a variable effective spatial resolution is provided. This allows one to
probe small radiation fields intersecting the detector at different spatial resolutions. In
particular, a functional relationship between the dose in phantom, DM, and the
transmission dose, TM, as a function of detector to surface distance (Dsd) was derived.
The Dsd values were varied from 0.3 cm to 24 cm and the area of the radiation field that
can be used to derive the dose in phantom for arbitrary radiation fields was found to be
based on the transmission dose measurements. The calculated IMRT planar dose at dmax
illustrated good agreement when compared with dose predicted by the TPS and measured
using EBT3 film. The poor pass rate for the gamma criteria of 1%/1mm can be explained
by possible submillimeter misalignment of registration of the film in the MP512T frame
of reference in TM and for the case of the TPS, by the voxel size in the dose calculation
which is larger than 1mm3. The registration of the same MP512T in the DM coordinate
system relative to the MP512T in TM is more accurate however. In addition, both
detectors have a pixel size of 0.5x0.5 mm2, which is less than 1x1 mm2. The obtained
result confirms that the MP512T can provide dose mapping at dmax with a spatial
resolution of order 1 mm and this is important for a small treatment fields such as those
used in SRS.
Since SRS and SBRT employ small radiation fields to conform the radiation dose tightly
to the target, meaningful treatment verification requires QA tools having a high spatial
resolution that accurately provide relevant dose information. The MP512T employed in
this work as a transmission detector has the potential to be used for real-time dose
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monitoring of small radiation fields, opening the door to real time 3D dose verification,
based on transmission measurements as the treatment is being delivered to the patient.
Hence, this work represents the first step in the development of real-time 3D dose
reconstruction based on TM measurements.
Note that the effective measurement area of measurement (Ao) at dmax can be
obtained from the sensitive area ATM of the MP512T as a function of Dsd as follows, cf.
Equation 6.4.
𝐿+1.5 2

𝐴0 = 𝐴𝑇𝑀 (𝐿−D ) ……………………………………… (6.4)
𝑠𝑑

Where, L is a source to surface distance, which for conventional linear accelerators is 100
cm.

6.5 Conclusions

The work described in his chapter demonstrates that the dose in a phantom can, in
principle, be calculated at any depth of interest based on the transmission measurements
made with the MP512T detector. The calculated dose for regular field sizes and intensity
modulated fields for a clinical case have shown good agreement when compared with the
dose predicted by the TPS and measured using EBT3 film. This study demonstrates the
potential of our pixelated monolithic silicon detector as a transmission detector that can
be used for small field QA, and that has the potential to be used for real-time 3D dose
reconstruction as therapy is delivered.

114

CHAPTER 7
CONCLUSION AND FUTURE WORK
Radiation therapy has become one of the main treatment options for cancer over the last
several decades with over 50% of patients having some form of radiation therapy as part
of their cancer management plan. There is a contribution to modern radiotherapy
techniques, such as IMRT, VMAT and SRS/SBRT. These sophisticated treatment
techniques enable the high-energy X-ray beam to be adjusted, changing the beam shape
and intensity to conform better to the shape of the tumours while sparing the radiation
dose to the normal healthy tissue. The concentrated radiation dose techniques use many
multileaf collimators that can move independently in the beam path in order to block the
beam and generate the high precision in millimetre sized radiation dose voxels.
The movement of the leaves is controlled and optimized by the calculation algorithm from
the treatment planning system. There are more parameters that the system uses for
computing the expected dose distribution in the patient such as beam energy, delivery
time, type of tissue in the beam line, etc. To check if all parameters for this complex plan
are correct, sophisticated treatment planning verification is needed. The verification
method ensures the treatment plan delivers the radiation dose so as to match well to the
dose delivered to the patient.
Online treatment verification is needed during the treatment delivery. Using such a
method, any errors can be detected in real-time, and the treatment can be stopped
immediately and re-planned to accommodate for the error. The additional software and
hardware that are required for this decision are not related to the work presented this
thesis.
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The CMRP at UOW has developed a 2D monolithic silicon diode detector array known
as “Magic Plate512” for in-phantom dosimetry and transmission measurements with
millimetre spatial resolution that is variable.
In this thesis, in-phantom dosimetry has been studied. The effect of the air gap size above
the detector was investigated and its impact on the measured output factor, wedge beam
profile and percentage depth dose for both photon and electron beams. In this study, the
suitable air gap was optimized for each beam energy utilized.
The output factor measured with the MP512 reduced with the increase of the detector air
gap at the smaller radiation field size. The MP512, with the air gap of 0.5 mm and 1.2
mm, show good agreement to the output factors measured with the EBT3 film and
MOSkin within ±2% for 6 MV photon beam fields and 10 MV, respectively.
The optimal air gap size for 6 MV and 10 MV energy was confirmed through similar
results for the expected PDD measurement. The PDD measured by MP512 with a 0.5 mm
(for 6 MV) and 1.2 mm (for 10MV) air gap size was within ±3% of the EBT3 for the 2 x
2 cm2 field for both photon energies. For the larger fields such as 5x5 cm2, and 10x10
cm2, the PDD measured with the MP512 is within ±1.6% and ±1.5% of that measured
using a Markus IC for 6 and 10 MV fields respectively.
The thesis used the optimal air gap size of 0.5 mm for 6 MV and 1.2 mm for 10 MV for
wedge beam profile measurements. As expected, the difference between the beams
profile measured by the MP512 and EBT3 film increases with increasing the air gap size.
The air gap causes a measurable dose reduction for small radiation fields due to the loss
of electronic equilibrium.
The thesis also investigated the effect of the air gap size above the MP512 detector for
various energies of electron beams. However, the effect on electron beam is not
significant due to an electronic equilibrium being fully established and maintained.
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The MP512, with a different detector packaging incorporated into the design was called
MP512T. The detector is 0.45 mm thick and was then used as a transmission type
detector. This thesis came up with, and demonstrated, the idea of the adjustable effective
detector spatial resolution by placing the MP512T on a movable stand and moving the
detector in the direction between the target in the patient and the Linac head.
By moving the detector between the patient and the Linac head it is possible to change
the effective spatial resolution for dosimetry in a monitored radiation field. These
detectors allow us to obtain a variable effective spatial resolution from 2 mm to 4 mm for
the MP512T detector. For a small tumour size, placement of the detector closer to the
patient will improve the spatial resolution in transmission mode, while monitoring of the
whole radiation field is still possible.
In this thesis, the influence of the MP512 on the beam was studied. In particular any
perturbation measured as a change in the surface dose and beam transmission factors were
investigated when operating the MP512T in transmission mode and with the MP512T
placed at various distances from the solid water phantom.
When placing the detector at the distance of above 18 cm above the phantom surface
produced only a small perturbation of the surface dose, measured as an increase in surface
dose by less than 5%. The increase in surface dose was negligible for radiation field sizes
of 5 x 5 cm2. The difference in surface dose between MP512T faced up and faced down
showed only a 2% difference. The effect of the PCB without the detector mounted on the
surface also indicated that at the distance of more than 18 cm, the percentage difference
is close to zero for all irradiated field sizes. The PCB alone increased the surface dose by
about 60% compared to the increase in the surface dose from the MP512T. Due to the
Compton Effect electrons are mostly created at the MeV range, and this suggests that an
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opening or recess in the PCB under the active area of the silicon monolithic detector is
recommended to reduce the increase in skin dose for all the considered IFSs.
The measurement of transmission coefficient of the MP512T detector at d max is close to
1 as the distance between the MP512T detector and the phantom surface decreased below
18 cm. The PCB under the silicon monolithic detector makes the transmission coefficient
closer to 1 for any placement of the proposed transmission detectors between patient and
the Linac head.
In this thesis, the use of the MP512T as a transmission-type detector was studied in more
detail with an example of a real clinical scenario. The correlation of the transmission
mode response (TM) and dose mode response (DM) of the MP512T for different detector
to surface distances (Dsd) and treatment field sizes were used to predict the dose at dmax.
The optimal air gap size above the detector for 6MV photon beam (0.5 mm) was applied
for the dose mode measurement of MP512 at dmax. For TM, the MP512T was positioned
at various values of Dsd. The results showed that a correlation between TM and DM
existed and could be employed to predict the dose at dmax.
When placing the MP512T at a Dsd of 4 cm and 24 cm, the predicted dose for a regular
field size of 1x1 cm2 fell within 2.18% compared to the measured dose. The predicted
dose when placing the MP512T at the same Dsd for 4 x 4 cm2 fell within 1.95% of the
measured dose.
The performance of the MP512T when used to calculate the dose for the clinical IMRT
plan was in good agreement with the TPS and the EBT3 film. The gamma criterion of
3%/3mm pass rate was 98.14% for Dsd 4 cm and 90.5% for Dsd 24 cm. The pass rate of
2%/2mm was 97.22% for Dsd 4 cm and 93.8% for Dsd 24 cm.
Future work will be to develop the real-time high spatial resolution 3D dose
reconstruction algorithm based on the TM measurements using the MP512T. Moreover,
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the mechanical realization of proposed transmission detector will be realized on a
telescopic jig attached to the Linac head block tray slot together with a wireless reader
developed at CMRP.
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Appendix A
Solid works drawing
The detector holder with specific geometries were designed for particular part of this
thesis. A 3D drawing was generated by using Solid works (Das-sault Systems SolidWorks
Corporation, Massachusetts, USA)

A.1 The transmission Magic Plate 512 (MP512T) detector holder

The special holder shows in Figure A.1 was used for the work descripted in Chapter 5
and Chapter 6.

Figure A.1: The transmission Magic Plate (MP512T) detector holder

Appendix A: Solid works drawing

A.2 The movable stand detector holder

The movable sand detector holder shows in Figure A.2 was used in the work described in
Chapter 5 and Chapter 6.

Figure A.2: The movable stand detector holder
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Appendix B
Matlab Scripts
Matlab script was designed by using Matlab (The MATHWORK Inc.) to manage the data
involved in the thesis.
B.1 EBT3 Film Center Location

This script was used to find the center of the EBT3 film.
function [x0,y0] = center(A)
if size(A,3)== 3
A = double(rgb2gray(A)); %Do image to gray scale
end
[row,col] = size(A); % Find the size of the image
%% Determine location * image value
Mx = ones(row,1)*(1:col).*A;
My = (1:row)'*ones(1,col).*A;
%% Determine the total value summation
area = sum(A(:));
% check for zero values
if area == 0 % central mass on uniform image
x = row/2;
y = col/2;
else
% Calculate centroids
x = sum(Mx(:))/area;% centroid location of x
y = sum(My(:))/area;% centroid location of y
end
if nargin==2 && pix
x = round(x); %x is the center of coll
y = round(y); %y is the center of raw
end
% Make in the integer number
y0=round(x); %switch to X axis when x is a position of column
x0=round(y); %switch to Y axis when y is a position of row
end
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B.2 MP512 Pixel Interpolation

There was some dead pixel during the measurement by MP512. This script was used to
interpolate between the functional detector pixel and the dead one.

function [ newdata ] = InterpolateHelper( data )
warning('off','all')
warning
newdata = zeros(24,24);
[n_rows, n_columns] = size(data);
newdata(1,:) = data(1,:);
newdata(:,1) = data(:,1);
newdata(24,:) = data(24,:);
newdata(:,24) = data(:,24);
fprintf('Start row pass');
%row pass
for n=2:n_rows-1
check = 1;
while(check)
fprintf('Start rows %d\n', n);
focus = data(n,:);
line = [1:24];
[fitresult, gof] = createFit(line, focus);
prompt = 'How many pixels do you want to interpolate:';
n_pixels = input(prompt);
if n_pixels > 0
fix_pixels = [];
for n_pixel=1:n_pixels
fprintf('What is the pixel No. %d that you want to
fix',n_pixel);
promt = ':';
fixing_pixel = input(promt);
fix_pixels(n_pixel) = fixing_pixel;
end
[fitResult, gof ] = createFit2(line, focus,
fix_pixels);
for n_pixel = 1:n_pixels
pixel = fix_pixels(n_pixel);
focus(fix_pixels) = fitResult(fix_pixels);
end
end
createFit(line, focus);
newdata(n,:) = focus;
prompt = '0 = ok, 1 = redo';
check = input(prompt);
close all;
end
end

fprintf('Start column pass');
% column pass
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for n=2:n_columns-1
check = 1;
while(check)
fprintf('Start column %d\n', n);
focus = newdata(:,n);
line = [1:24];
[fitresult, gof] = createFit(line, focus);
prompt = 'How many pixels do you want to interpolate:';
n_pixels = input(prompt);
fix_pixels = [];
if n_pixels > 0
for n_pixel=1:n_pixels
fprintf('What is the pixel No. %d that you want to
fix',n_pixel);
promt = ':';
fixing_pixel = input(promt);
fix_pixels(n_pixel) = fixing_pixel;
end
[fitResult, gof ] = createFit2(line, focus,
fix_pixels);
for n_pixel = 1:n_pixels
pixel = fix_pixels(n_pixel);
focus(fix_pixels) = fitResult(fix_pixels);
end
end
createFit(line, focus);
newdata(:,n) = focus;
prompt = '0 = ok, 1 = redo';
check = input(prompt);
close all;
end
end
end

B.3 Gamma Evaluation

This script is used for calculated the gamma evaluation described in chapter 6.
function [GammaMap numpass avg numWithinField] = GammaCompare(Image1,
Image2,x_size,y_size,EPIDppx, Dose_tol, DTA_tol, FE_thresh, rad,
varargin)
% Compare Image2 to reference image (TPS) Image1
% rad: radius - in points - need to work out before pass
% GAMMA settings
% x_size = image x size
% y_size = image y size
% Dose_tol = DoseTol; % Percent of maximum dose. Given as a fraction
% DTA_tol = DistTol; % cm
% FE_thresh = ThreshFx; % Given as a fraction
% rad = radius; distance in cm to search
% Note: DTA tolerance and specified X, Y points must be in the same
units
% example
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% [GammaMap numpass avg numWithinField] = GammaCompare(img1, im2,
1024, 768,0.0392, 0.03, 0.3, 0.1,5);

debuglevel = 0;
% EPID pixel size spacing (EPIDppx) = 0.0392 (1024X768); =0.0784
(512X384)
% - AS1000 EPID
xp = (1:x_size)*EPIDppx;
yp = (1:y_size)*EPIDppx;
res_x = xp(2) - xp(1);
res_y = yp(2) - yp(1);
% if radius not specified, compute a sensible one
% Expand DTA tolerance by 50%. Use this as a search radius
if ~exist('rad','var') || isempty(rad)
radlim = DTA_tol * 1.5;
rad = min(ceil(radlim/res_x),ceil(radlim/res_y));
end
MaxVal = max(Image1(:));
Mask = zeros(size(Image1));
crit_val = FE_thresh*MaxVal;
% Use the Resampled image for this - EPID no spikes?
Mask(Image1>crit_val) = 1;
Dose_tol = Dose_tol*MaxVal; % GLOBAL - PERCENTAGE OF MAX DOSE
if debuglevel > 1
fprintf('Maximum dose for Gamma: %2.1f cGy\n',MaxVal);
fprintf('Dose Tolerance for Gamma: %2.1f cGy\n',Dose_tol);
fprintf('DTA: %2.1f\n', DTA_tol);
fprintf('FE_thresh: %2.1f\n', FE_thresh);
fprintf('rad: %2.1f\n', rad);
fprintf('Image 1 val: %2.1f\n',Image1(round(size(Image1,1)/2),
round(size(Image1,2)/2)));
fprintf('\n');
end
% VECTORIZED CALCULATION STARTS HERE
% GammaMapsub will carry the calculated gamma values for the truncated
% images. GammaMap2 will be the Gamma values for the full image.
GammaMapsub = NaN;
GammaMap = zeros(size(Image1));
% Find the threshold limits for truncation
[validmask_y validmask_x] = find(Mask);
min_x = min(validmask_x)-rad;
max_x = max(validmask_x)+rad;
min_y = min(validmask_y)-rad;
max_y = max(validmask_y)+rad;
if min_x < 1
min_x = 1;
end
if min_y < 1
min_y = 1;
end
if max_x > size(Image1,2)
max_x = size(Image1,2);
end
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if max_y > size(Image1,1)
max_y = size(Image1,1);
end
% Truncate the images to avoid needless calculations
Im1 = Image1(min_y:max_y,min_x:max_x);
Im2 = Image2(min_y:max_y,min_x:max_x);
% Shift the image by varying amounts. Determine the minimum gamma
value
% for all shifts
for i=-rad:rad
for j=-rad:rad
% circshift function wraps elements from top to bottom as
necessary
% The entire image is shifted at once
Im2_shift = circshift(Im2,[i j]);
dist = sqrt((res_y*i)^2 + (res_x*j)^2);
DoseDiff = Im2_shift - Im1;
% Compute the gamma map for this particular shift value
Gamma_temp = sqrt((dist./DTA_tol).^2 +
(DoseDiff./Dose_tol).^2);
% Accumulate the map of the minimum values of gamma at each
point
GammaMapsub = min(GammaMapsub,Gamma_temp);
end
end
% Put the truncated gamma map back into its proper location within the
full
% gamma map
GammaMap(min_y:max_y,min_x:max_x) = GammaMapsub;
% Remove any edge effects from the circular shifting by multiplying by
the
% mask values. This will negate any calculated gamma values around the
% edges of the distribution where this effect would arise
GammaMap = GammaMap .* Mask;
% Ensure that NaN values outside the mask do not affect the
calculation
GammaMap(~Mask) = 0.0;
% Compute statistics
numWithinField = nnz(Mask);
numpass = nnz(GammaMap<1 & Mask)./numWithinField;
avg = sum(GammaMap(:))./numWithinField;
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